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resumo 
 
 
Neste trabalho é descrita a síntese de porfirinas regulares e N-confusas 
com o objetivo da realização de estudos acerca da sua eficiência como 
fotossensibilizadores (PSs) em terapia fotodinâmica (PDT) e a influência 
desta no splicing alternativo do mRNA. Os derivados porfirinicos foram 
preparados tendo como estrutura base a 5,10,15,20-tetraquis(1-
metilpiridinio-4-il)porfirina.  
Inicialmente irá ser realizada uma breve introdução sobre os macrociclos 
tetrapirrólicos, nomeadamente sobre porfirinas. Segue-se o capítulo 2 
onde há a descrição sintética dos derivados porfirínicos usados neste 
trabalho. Desta forma, através das condições estabelecidas por Lindsey 
foram sintetizadas duas porfirinas: 5,10,15,20-tetraquis(4-
bromometilfenil)-2-aza-21-carboporfirina e a 5,10,15,20-tetraquis(4-
bromometilfenil)porfirina e procedendo-se à sua cationização com 
piridina que originou os derivados 5,10,15,20-tetraquis(4-(piridinio-1-il-
metil)fenil)-2-aza-21-carboporfirina e 5,10,15,20-tetraquis(4-(piridinio-
1-il-metil)fenil)porfirina. A formação das porfirinas neutras ocorreu com 
baixo rendimento, mas a sua cationização foi conseguida com 
rendimentos acima dos 80%. Neste mesmo capítulo ainda são 
apresentadas as caracterizações fotofísicas de todos os derivados 
porfirínicos, nomeadamente fluorescência e geração de oxigénio singleto. 
As porfirinas regulares foram aquelas que demonstraram bons 
rendimentos quânticos de fluorescência e capacidade para gerar oxigénio 
singleto em DMF.  
No capítulo 3 são descritos todos os estudos biológicos realizados neste 
trabalho. Inicialmente foram realizados estudos de viabilidade celular em 
células MCF-7 e HeLa usando o teste com WST-1 e ATPliteTM e como 
PS de referência a 5,10,15,20-tetraquis(1-metilpiridinio-4-il)porfirina. 
Foram realizados estudos de concentração (0.1 µM-5.0 µM) e tempo de 
irradiação (0, 5, 10 e 15 min). 
A 5,10,15,20-tetraquis(4-(piridinio-1-il-metil)fenil)porfirina revelou ser o 
melhor PS, tendo sido selecionado um tempo de irradiação de 15 min e 
uma concentração até 5 µM para o estudos subsequentes. Os estudos de 
localização subcelular e uptake revelaram que a 5,10,15,20-tetraquis(4-
(piridinio-1-il-metil)fenil)porfirina entra nas células mas  não se localiza 
no núcleo como acontece com o controlo positivo. São ainda descritos 
estudos acerca do tipo de morte celular que as células podem sofrer depois 
da PDT com estes PSs. Por fim os estudos da influência da terapia 
fotodinâmica no splicing alternativo mostrou que a 5,10,15,20-
tetraquis(4-(piridinio-1-il-metil)fenil)porfirina e a 5,10,15,20-tetraquis(1-
metilpiridinio-4-il)porfirina parecem induzir um ligeiro splicing 
alternativo do mRNA.  
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abstract 
 
In this work the synthesis of regular and N- confused porphyrins with 
the objective of assessing its efficiency as photosensitizers (PSs) in 
photodynamic therapy (PDT) and its influence in alternative splicing 
of mRNA is described. The porphyrin derivatives were prepared 
having as a template the 5,10,15,20-tetrakis(1-methylpyridynium-4-
yl)porphyrin. 
Initially, a brief introduction about tetrapyrrolic macrocycles, namely 
about porphyrins will be done. Then, chapter 2 will follow with the 
synthetic description of the porphyrin derivatives used in this work. 
Through Lindsey conditions, two porphyrins were synthesized: 
5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-carbaporphyrin; 
5,10,15,20-tetrakis(4-bromomethylphenyl)porphyrin  and then we 
proceeded to their cationization with pyridine to give: 5,10,15,20-
tetrakis(4-(pyridynium-1-yl-methyl)phenyl)-2-aza-21-
carbaporphyrin and 5,10,15,20-tetrakis(4-(pyridynium-1-yl-
methyl)phenyl)porphyrin. The formation of the neutral porphyrins 
occurred with low yield but its cationization was achieved with yields 
higher than 80%. In the same chapter, the photophysical 
characterization of all porphyrins, namely singlet oxygen production 
and fluorescence quantum yield were described. The regular 
porphyrins demonstrated good fluorescence quantum yields and 
ability to generate singlet oxygen in DMF.  
In chapter 3, all the biological assays done in this work are described. 
Initially, cellular viability studies were done in MCF-7 and HeLa cells 
using the WST-1 reagent and ATPliteTM and as PSs reference the 
5,10,15,20-tetrakis(1-methylpyridynium-4-yl)porphyrin. Studies of 
concentration (0.1 µM-5.0 µM) and irradiation time (0, 5, 10 and 15 
min) were also done. The 5,10,15,20-tetrakis(4-(pyridynium-1-yl-
methyl)phenyl)porphyrin showed to be the best PS and 15 min 
irradiation and a concentration up to 5 µM for the following studies 
were selected. The subcellular localization and uptake studies revealed 
that 5,10,15,20-tetrakis(4-(pyridynium-1-yl-methyl)phenyl)porphyrin 
can enter the cells but it is not localized in the nucleus, contrary to 
5,10,15,20-tetrakis(1-methylpyridynium-4-yl)porphyrin. The studies 
regarding type of cell death that cells undergo after PDT treatment 
were also assessed. At last, the 5,10,15,20-tetrakis(4-(pyridynium-1-
yl-methyl)phenyl)porphyrin and 5,10,15,20-tetrakis(1-
methylpyridynium-4-yl)porphyrin seemed to induce a small 
alternative splicing of mRNA. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Index 
University of Aveiro  xiii 
Index 
Abbreviations ........................................................................................................... xvii 
CHAPTER 1 ..................................................................................................................... 1 
1.1 Tetrapyrrolic Macrocycles ..................................................................................... 3 
1.1.1 General Remarks ............................................................................................ 3 
1.1.2 Nomenclature of the tetrapyrrolic macrocycle ............................................... 4 
1.1.3 Physicochemical properties of porphyrin derivatives and N-confused 
porphyrins ..................................................................................................................... 5 
1.1.4 Reactivity of the tetrapyrrolic macrocycles ................................................... 9 
1.1.5 Synthesis of porphyrinic macrocycles.......................................................... 11 
1.1.6 Applications ................................................................................................. 17 
1.1.7 Photodynamic process .................................................................................. 17 
1.2 PDT and alternative splicing ............................................................................... 21 
1.2.1 General background ..................................................................................... 21 
1.2.1.1 Photodynamic therapy as a new alternative to cancer treatment .......... 21 
1.2.1.2 The photosensitizers ............................................................................. 21 
1.2.1.3 Subcellular localization ......................................................................... 22 
1.2.1.4 Effects of PDT and Immune Response ................................................. 22 
1.2.2 Cell Death: apoptosis, necrosis and autophagy ............................................ 23 
1.2.3 The alternative splicing process ................................................................... 25 
1.2.4 Alternative splicing and cancer .................................................................... 26 
1.3 Aim of Work ........................................................................................................ 27 
CHAPTER 2 ................................................................................................................... 29 
2.1 N-Confused-porphyrin and porphyrin synthesis .............................................. 31 
2.1.1 General remarks ........................................................................................ 31 
2.1.2 Synthesis of the precursors 5,10,15,20-tetrakis(4-bromomethylphenyl)-2-
aza-21-carbaporphyrin and 5,10,15,20-tetrakis(4-bromomethylphenyl)porphyrin 33 
Index 
xiv   University of Aveiro 
2.1.3 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-
methyl)phenyl)porphyrin tetraiodide (6) and 5,10,15,20-tetrakis(4-(pyridinium-1-
yl-methyl)phenyl)-2-aza-21-carbaporphyrin tetraiodide (2) .................................. 38 
2.2 Photophysical Characterization ....................................................................... 42 
2.3 Material and methods ....................................................................................... 48 
2.3.1 Chemicals and equipment ......................................................................... 48 
2.3.2 Synthesis of 4-bromomethylbenzaldehyde (4) ......................................... 49 
2.3.3 Synthesis of 5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-
carbaporphyrin (1) and 5,10,15,20-tetrakis(4-bromomethylphenyl)porphyrin (5) 50 
2.3.4 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl) 
porphyrin tetraiodide (6) ......................................................................................... 51 
2.3.5 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)-2-aza-
21-carbaporphyrin tetraiodide (2) ........................................................................... 52 
2.3.6 Irradiation conditions for 1O2 generation.................................................. 52 
2.3.7 Singlet oxygen generation ........................................................................ 53 
CHAPTER 3 ................................................................................................................... 55 
3.1 General remarks ................................................................................................... 57 
3.2 Viability assays .................................................................................................... 57 
3.2.1 Measurement of cell viability using the Cell Proliferation Reagent WST-1 57 
3.2.1.1 Cell viability assay with WST-1 in HeLa Cells .................................... 58 
3.2.1.2 Cell Viability assay with WST-1 in MCF-7 Cells ................................ 59 
3.2.2 Cell viability assay using ATPliteTM kit ....................................................... 64 
4.2.2.1 Dose dependence assay ......................................................................... 64 
4.2.2.2 Time post-PDT dependence assay ........................................................ 66 
3.2.3 Cell viability assay using Trypan Blue ........................................................ 67 
3.3 Cellular uptake ..................................................................................................... 70 
3.4 Subcellular localization ....................................................................................... 72 
Index 
University of Aveiro  xv 
3.5 Type of cell death induced by photodynamic therapy with porphyrin 6 and 
TMPyP ............................................................................................................................ 74 
3.5.1 General background ..................................................................................... 74 
3.5.2 General procedure to access type of cell death ............................................ 76 
3.5.3 Apoptosis and necroptosis pathway - the cleavage of PARP-1 ................... 77 
3.5.4 Autophagy – Transformation of LC3-I into LC3-II ..................................... 78 
3.5.5 Necroptosis- Release of Cyclophilin A ........................................................ 79 
3.6 Influence assessment of photodynamic therapy in alternative splicing of mRNA
 80 
3.7 Material and methods .......................................................................................... 86 
3.7.1 Solutions and buffers .................................................................................... 86 
3.7.2 Statistical analysis ........................................................................................ 88 
3.7.3 Eukaryotic cell line and cell culture ............................................................. 88 
3.7.4 Photodynamic treatments ............................................................................. 88 
3.7.5 Light source .................................................................................................. 89 
3.7.6 WST-1 assay ................................................................................................ 89 
3.7.7 ATPliteTM kit assay ...................................................................................... 89 
3.7.8 Trypan Blue assay ........................................................................................ 90 
3.7.9 Cellular uptake ............................................................................................. 90 
3.7.10 Subcellular localization ................................................................................ 90 
3.7.11 The Western Blot Technique........................................................................ 91 
3.7.12 Protein extraction ......................................................................................... 93 
3.7.11.1 Harvest .................................................................................................. 93 
3.7.11.2 Total Protein extraction ........................................................................ 94 
3.7.11.3 Protein Dosage ...................................................................................... 94 
3.7.11.4 SDS-Page and Immuno-detection (Western Blotting) .......................... 94 
3.7.13 Total RNA extraction ................................................................................... 96 
Index 
xvi   University of Aveiro 
3.7.14 RNA dosage ................................................................................................. 96 
3.7.15 Generation of cDNAs by reverse transcriptase and amplification by PCR . 96 
3.7.16 Analysis on polyacrylamide gel 10% ........................................................... 99 
CHAPTER 4 ................................................................................................................. 101 
4. Conclusion and future outcomes. ......................................................................... 103 
5. References ............................................................................................................ 107 
Abbreviation List 
University of Aveiro  xvii 
Abbreviations
1,2 DBB 
A 
A.U 
A0 
AMZ2 
AS 
ATF3 
ATP 
BSA 
cDNA 
cm2 
CoASY 
CPT 
DDQ 
DMEM 
DMF 
DMSO 
DNA 
DPiBF 
ESI 
FBS 
H2TPyNCPP 
 
H2TPyTPP 
HMBC 
HRP 
HSP60 
HSQC 
ISC 
IUPAC  
J 
LC3 
 
1,2-Dibenzoylbenzene 
Absorbance 
Arbitrary Units 
Absorbance at time zero 
Archaelysin family metallopeptidase 2 
Alternative splicing 
Activating Transcription Factor 3 
Adenosine triphosphate 
Bovine serum albumin 
Complementary DNA 
Square centimeter 
Coenzyme A synthase 
Camptothecin  
2,3-Dichloro-5,6-dicyano-p-benzoquinone 
Dulbecco's Modified Eagle's medium 
Dimethylformamide 
Dimethylsulfoxide 
Deoxyribonucleic acid 
Diphenylisobenzofuran 
Electrospray ionization  
Fetal bovine serum 
5,10,15,20-tetrakis(pyridyl- 
4-yl)-2-aza-21-carbaporphyrinn 
5,10,15,20-tetrakis(pyridyl-4-yl) porphyrin 
Heteronuclear Multiple Bond Correlation spectroscopy 
Horseradish peroxidase 
Heat Shock Proteins with 60 kDa 
Heteronuclear single quantum coherence spectroscopy 
Intersystem crossing 
International Union of Pure and Applied Chemistry 
Coupling constant 
Microtubule-associated protein 1A/1B-light chain 3 
 
Abbreviation List 
xviii   University of Aveiro 
Ln 
m 
m/z 
MCF-7 
MDM2 
min 
MMS 
mRNA 
MSA  
mW 
NCP 
NCTPP 
nm 
NMR  
PARP 
PBS 
PCR 
PDT  
ppm 
PS 
PVDF 
RBM4 
RNA  
ROS 
RT-PCR 
s 
s 
SDS-PAGE 
 
SRSF1 
 
 
 
 
Napierian logarithm 
Multiplet  
mass/charge ratio 
Human breast adenocarcinoma cell line 
Mouse double minute 2 homolog 
minutes/minute 
Methyl methanesulfonate 
Messenger ribonucleic acid 
Methanesulfonic acid 
Milliwatts 
N-Confused porphyrin 
5,10,15,20-tetraphenyl-2-aza-21-carba-porphyrin 
nanometers 
Nuclear magnetic resonance 
Poly (ADP-ribose) polymerase 
Phosphate-buffered saline 
Polymerase chain reaction 
Photodynamic therapy 
Parts per million 
Photosensitizer 
Polyvinylidene fluoride 
RNA- binding protein 4 
Ribonucleic acid 
Reactive oxygen species 
Reverse transcriptase polymerase chain reaction 
Singlet  
Second/seconds 
Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
Serine/arginine-rich splicing factor 1 
 
 
 
 
Abbreviation List 
University of Aveiro  xix 
t 
TBST 
TEMED 
TFA 
THF 
TLC 
TPP 
UV-Vis 
VEGF111 
WST-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Triplet 
Tris-buffered saline and Tween 20 
Tetramethylethylenediamine 
Trifluoroacetic acid 
Tetrahydrofuran 
Thin layer chromatography 
5,10,15,20- tetraphenylporphyrin 
Ultraviolet-Visible 
Vascular Endothelial Growth Factor-111 
Water soluble tetrazolium salt 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
Introduction: Tetrapyrrolic Macrocycles: 
porphyrins, N-Confused Porphyrins and the 
alternative splicing process of mRNA and its 
correlation with cell death in cancer 
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1.1 Tetrapyrrolic Macrocycles 
1.1.1 General Remarks 
In general, the designation porphyrin is given to a family of compounds with intense 
colour formed by a nucleus of four units of pyrrole type joined by methinic bridges.1 The 
designation porphyrin derives from the Greek term “porphura” which was used to describe 
the colour purple.  
Porphyrins are also known as “the pigments of life” due to their important role in 
some biological processes like respiration, photosynthesis and electron transport.2 In fact, 
the prostetic group of haemoproteins, as haemoglobin and myoglobin is a tetrapyrrolic 
macrocycle denominated heme group. This heterocyclic system coordinated with iron(II) by 
the four nitrogen atoms of the porphyrin core is able to bind reversibly to molecular oxygen 
and is responsible for the oxygen transportation and storage through the body (Figure 1-A).3 
Chlorophylls are green pigments responsible for absorbing light and retain it in 
specific molecules.4 This type of pigments has a porphyrin-type core similar to the heme 
group (Figure 1-B). However, instead of an iron ion, the inner core of the tetrapyrrolic 
macrocycle is coordinated with magnesium. Furthermore, one of the pyrrolic units in 
chlorophyll is reduced and the acid groups are esterified.3 
 
 
Figure 1. Structures of heme group (A) and chlorophylls (B). 
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Tetrapyrrolic macrocycles are also present in other biological systems like 
cytochromes, which are involved in electron transfer,5 cellular energy production,6 
biosynthesis of steroids7 and detoxification mechanisms.8  
An important contribution for the development of this field is due to Hans Fisher who  
received the Nobel prize in Chemistry9 in 1930 for his investigation in the composition of 
the heme group but mostly for its synthesis. He also reported the resemblance of the heme 
groups with the pigments responsible for the photosynthesis3 and showed that these pigments 
have similar skeleton of porphyrins.9 
 
 
1.1.2 Nomenclature of the tetrapyrrolic macrocycle 
There are two types of nomenclature to indicate the name of porphyrins and 
analogues (Figure 2).1,2 In the first one, due to H. Fischer, the pyrrole rings are denominated 
as A, B, C and D, the β-pyrrolic positions are numbered from 1 to 8 and the meso-positions 
are indicated by the Greek letters α, β, δ and γ. Posteriorly, IUPAC also created nomenclature 
rules for numerating this type of macrocycles, in which the numbers 5,10,15 and 20 
correspond to the meso positions and the 2,3,7,8,12,13,17 and 18 ones are indicative of β-
pyrrolic positions. In this work, the nomenclature used was the one proposed by IUPAC.  
 
Figure 2. Nomenclature of tetrapyrrolic macrocycles proposed by Fischer and IUPAC, respectively 
  
The tetrapyrrolic nucleus can also occur in chlorins, bacteriochlorins, corroles, 
calix[4]pyrroles, phtalocyanines among others. Additionally, there is a type of porphyrins 2-
aza-21-carbaporphyrin called N-confused porphyrins (NCP), which will be also very 
relevant to the present work. So, in this chapter, some considerations about the unique 
characteristics of this type of porphyrins are made. 
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 A N-confused porphyrin is an isomer of a “regular” porphyrin with an inverted 
pyrrole ring linked to the meso carbons through an α and β position.10 This type of 
compounds can also be numbered according to IUPAC nomenclature as it is shown in 
Figure 3. It is important to highlight that in N-confused porphyrins the nitrogen in the 
inverted pyrrole ring is numbered as 2. 
 
Figure 3. IUPAC recommendation to the N-confused porphyrinic core numeration. 
 
 
1.1.3 Physicochemical properties of porphyrin derivatives and N-confused 
porphyrins 
Porphyrins have 22 π electrons but only 18 of these are involved in electronic 
delocalization, in order to satisfy the Huckel’s rule regarding aromaticity (4n+2π electrons, 
n=4).11 As it happens with porphyrins, N-confused porphyrins have 18 π electrons involved 
in delocalization and consequently are aromatic compounds.  
Also, when the porphyrin nucleus is reduced losing one double bond in one of the β-
pyrrolic positions, the new macrocycle designated by chlorin is still aromatic (Figure 4-a). 
The aromaticity is also maintained in derivatives known as bacteriochlorins with two 
opposite pyrrolic units reduced (Figure 4-b) and in isobacteriochlorins (Figure 4-c)where 
the reduction occurs in two contiguous pyrrolic units.12,13  
Chapter 1 
6   University of Aveiro 
 
Figure 4. Structures of reduced macrocycles like chlorin (a), bacteriochlorin (b) and isobacteriochlorin (c). 
  
Porphyrins and their derivatives can lose two internal protons and form complexes 
with the majority of metals in the periodic table, especially copper(II), zinc(II), iron(III), 
magnesium(II) and nickel(II). Tetrapyrrolic macrocycles, which do not appear coordinated 
with any metal, are usually denominated as free-bases.14 
 Porphyrins and their derivatives have unique absorption spectra. This type of 
macrocycles has in general a strong band around 400 nm denominated Soret band and 
several bands with lower intensity at 500-650 nm named Q bands.11,15 In the UV-Vis 
spectrum, the appearance of the Soret band is due to the delocalization of π electrons of the 
macrocycle; so this band appears also in chlorins, bacteriochlorins and isobacterochlorins 
although with different intensities.2,15  
Free-base porphyrins have four Q bands with increasing wavelength denoted as I, II, 
III and IV (Figure 5). The intensity ratio of the absorption bands in the porphyrins spectra 
depends on their structure. For example, when the relative intensities of these bands are in 
the order IV>III>II>I, the spectrum is called ethio-type (Figure 5 - a). 
 
Figure 5. Ethio (a), rhodo (b) and phylo (c)-type UV-Vis spectrum.16 
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In porphyrins with a rhodo-type spectrum the relative intensity of Q bands follows 
the sequence III>IV>II>I (Figure 5 b), and in the ones with phyllo-type spectrum the 
sequence is IV>II>III>I (Figure 5 c).16 As it can be seen in Figure 6, the UV-Vis spectrum 
of a chlorin has also four Q bands. Comparatively to porphyrins, the band I which is centred 
at 650 nm is much more intense. Bacteriochlorins have one strong absorption band I between 
700-750 nm. Isobacteriochlorins, in turn, have three Q bands with an increasing intensity 
from 500 to 600 nm. In general, the UV-Vis spectra of metalloporphyrins show only two Q 
bands due to the symmetry induced by the metal ion in the macrocycle core.2,11 These 
variations in position and intensity of the Q bands allow the distinction of reduced 
derivatives and if the macrocycle is coordinated or not with a metal in the inner core.17 
 
 
Figure 6. UV-Vis spectra in CH2Cl2 regarding a meso-substituted porphyrin and the corresponding reduced 
analogues bacteriochlorin, isobacteriochlorin and chlorin. 
 
The UV-Vis spectrum of a N-confused porphyrin in CH2Cl2 shows a red-shifted for 
the whole bands due to the macrocycle distortion from planarity. In the N-confused 
derivatives, the last band (band I) that appears at 725 nm is much more intense than the band 
I in porphyrins at 650 nm. In Figure 7 is shown the spectra of 5,10,15,20-
tetraphenylporphyrin (TPP) and of the corresponding N-confused porphyrin, the 5,10,15, 
20-tetraphenyl-2-aza-21-carbaporphyrin (NCTPP) where these features are patent.  
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Figure 7. UV-Vis spectra in CH2Cl2 of 5,10,15,20-tetraphenylporphyrin (TPP) and of 2-aza-5,10,15,20-tetraphenyl-
21-carbaporphyrin (NCTPP). 
 
As it can be seen in the spectra, the Q bands of NCTPP are distorted because band I 
becomes more intense than the band III and IV. It is important to highlight that when a 
substituent is introduced in the para positions of the phenyl moiety, the spectrum undergoes 
a red-shifted delocalization.16 
Another important technique that allows structural identification of these compounds 
is the Nuclear Magnetic Resonance (NMR). For meso-arylporphyrins, the signals 
corresponding to the resonance of the β-pyrrolic protons appear between δ 8-9 ppm and the 
signals corresponding to the resonance of the inner N-H appear at high field, between δ -2 
and -4 ppm.11,18 These chemical shifts are due to an anisotropic effect, caused by the 
electronic flow originated by π delocalized electrons, which protects the protons inside the 
ring and unprotects the ones outside it.18 Additionally, in case of meso-unsubstituted 
porphyrins the signals generated by the resonance of the meso protons appear at δ 10 ppm. 
As mentioned earlier, the saturation of β-pyrrolic bonds does not affect the aromaticity of 
the macrocycle but this reduction of peripheral double bonds leads to a decrease in the ring 
current. This is demonstrated by the upfield shift of peripheral proton signals and a down 
field shift of the N-H signals. This decrease is moderate in chlorins and bacteriochlorins but 
highly noted in isobacteriochlorins.11 
Regarding N-confused porphyrins, the 1H NMR of this type of compounds has 
characteristic signals in the high field region at δ -2.5 ppm for inner NH’s and at δ -5.1 ppm 
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corresponding to the inner CH.10,19 The β-pyrrolic protons give rise to several signals due to 
the asymmetry caused by the inverted pyrrole ring. 
 N-confused porphyrins have three inner core nitrogens and one peripheral. Given its 
asymmetric structure, six NH-tautomers can be formed. They can be separated into type-A 
and type B-tautomers. Type A possess [18] annulenic circuits and show strong aromaticity 
isomers. However, when the outer nitrogen is protonated the type-B tautomers are 
accomplished where the [18]annulenic circuits do not exist and the aromaticity is only 
moderate (Scheme 1).20,21 
 
Scheme 1. NH. -tautomerism of N-confused porphyrins.  
 
Another important feature of the tetrapyrrolic macrocycles are their solubility in 
organic solvents and their insolubility in water. However, the solubility in organic solvents 
depends on the substituents present in the pyrrolic rings, meso positions or in the macrocycle 
inner core coordination.23 
 
 
1.1.4 Reactivity of the tetrapyrrolic macrocycles 
Macrocycles may undergo some reactions either in the inner core or on the peripheral 
positions of the macrocycle.2,11,18 Reactions that occur in the inner core of the ring can 
involve N-alkylation processes23 or acid-base type reactions (Scheme 2). For instance, strong 
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induce the deprotonation of the inner NH leading to anionic species (P2--Scheme 2). These 
anions can suffer further alkylation. In addition, the formation of cationic species comes 
from the protonation of the other nitrogens in the presence of acids (PH3
+ and PH4
2+-Scheme 
2).24 
 
Scheme 2. Acid-base reactions that occur in the inner NH of porphyrin core. 
In the macrocycle’s inner core of the ring complexation with metallic ions can also 
occur. These reactions have great importance because either the absence or the presence of 
a metallic ion in the inner core can determinate the reactivity of the macrocycle. These 
metallic atoms can also protect the inner nitrogen atoms from nucleophilic attacks or 
protonation.2,18 
As well as aromatic hydrocarbons, porphyrins can suffer electrophilic aromatic 
substitution reactions namely formylation,25 halogenation,26 nitration,27 sulfonation,28 
alkylation29 and acylation.30 The reactions mentioned can occur in the meso and/or in the β-
pyrrolic positions.31,32  
N-confused porphyrins have a peripheral nitrogen atom which has less steric 
constraint, and it is much more nucleophilic than the interior nitrogen atoms; for that reason 
this nitrogen atom can be alkylated.33 Furthermore, N-confused porphyrins can undergo 
complexation with metals, alkylation in the inner carbon of the inverted pyrrole ring and 
acid-base reactions.34 Some common reactions which can be accomplished with N-confused 
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porphyrins are present in Figure 8. Regarding complexation, it can bind with many metallic 
ions but Figure 8 only shows the most common ones. 
 
Figure 8. Possible reactions for N-Confused Porphyrins.35–42 
 
 It is important to highlight that when complexing to palladium, it was reported that 
when this complexation is done with the outer nitrogen, dimers can be formed.39 Moreover, 
the complexation can also occur with the inner nitrogen. Regarding some other metallic ions, 
the complexation can occur in the outer nitrogen as well.36,40 
 
 
1.1.5 Synthesis of porphyrinic macrocycles 
In the past century, there were several research groups that studied and developed 
synthetic methods to prepare selectively meso-tetraarylporphyrins, corrole, cálix [4] pyrrole, 
phthalocyanines, expanded porphyrins like saphyrins and hexaphyrins and N-confused 
porphyrins (Figure 9).  
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Figure 9. Structures of some macrocycle derivatives. 
 
The synthesis of porphyrins derivatives can occur by several distinct pathways: 
through pyrrole intermediates, by introducing modifications in natural pigments or in pre-
synthesized porphyrins. In this chapter, it will be discussed the synthesis of 5,10,15,20-
tetraarylporphyrins and also of N-confused porphyrins since in this work it will be developed 
either “regular” and N-confused porphyrins. There are many synthetic approaches regarding 
meso-substituted porphyrins preparation, being the condensation between a pyrrole and an 
aldehyde the most common method. 
 The first synthetic route used to prepare meso-tetrasubstituted porphyrins was 
described by Rothemund in 1936 and it consisted in the condensation between pyrrole and 
aldehydes (Scheme 3). In his work, he could prepare 5,10,15,20-tetramethylporphyrin and 
porphine from the reaction of pyrrole with gaseous acetaldehyde and gaseous formaldehyde, 
respectively, in pyridine. The two reactional mixtures were heated in sealed tubes at 90-95ºC 
for 30 h under anaerobic conditions affording after this time the expected macrocycles.43 
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Scheme 3. Preparation of meso-tetrasubstituted porphyrins according to Rothemund conditions. 
  
After testing more than 25 aldehydes (aliphatic, aromatic and heterocyclic ones) with 
optimized conditions,44 Rothemund prepared and isolated TPP through condensation of 
pyrrole and benzaldehyde in pyridine at 220ºC for 48 h (Scheme 3). The porphyrin yield of 
this reaction was about 5% and it was contaminated with the correspondent chlorin. This 
contamination could vary depending on temperature and reactants concentration. However, 
the conclusions of Rothemund studies also showed that by adding the adequate agents like 
PbCrO4 or a mixture of calcium carbonate and magnesium oxide, the reaction yield could be 
increased.45 
 After the method proposed by Rothemund, in 1964 Alder and Longo suggested new 
conditions for preparation of meso-arylporphyrins (Scheme 4). The authors studied several 
reaction conditions such as solvents, absence or presence of salts and temperature range in 
order to optimize the reaction conditions in order to produce the desired porphyrins.46 
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Scheme 4. The best Adler-Longo conditions to prepare meso-arylporphyrins. 
 
The best conditions founded by these authors consisted in the reaction of pyrrole with 
the adequate aldehyde and refluxing it with propionic acid for 30 min at open air. Using 
these conditions, Adler and Longo synthetized TPP in 20% yield in a fast and reproducible 
way.47 This method is efficient to prepare porphyrins in a multi-gram scale due to the fact 
that porphyrins precipitate in the reactional mixture.47 However, this method has its own 
disadvantages such as the contamination with the corresponding chlorin48 and the 
impossibility of using aldehydes with functional groups sensible to acidic media.47 
 The conditions established by Alder-Longo are also used to synthetize asymmetric 
porphyrins. In this case, the stoichiometric amounts of the aldehydes must be adjusted to 
favour the formation of the desired derivative.47 
In order to prepare this type of macrocycles there is another approach developed by 
Rocha Gonsalves and later by Lindsey and co-workers. This method is based in three basic 
assumptions.49,50 
I) Pyrrole and aldehyde are very reactive species  
II) The formation of porphyrinogen, which is an intermediate without aromatic 
character, is thermodynamically favourable when the reaction between aldehyde 
and pyrrole occur in appropriate conditions; 
III) In order to reach equilibrium, the reaction conditions must be suitable for a wide 
variety of aldehydes. 
In 1985 Rocha Gonsalves proposed a method where the formation of porphyrinogen 
occurred through condensation of pyrrole and an aliphatic aldehyde in CCl4 with the 
presence of trifluoroacetic acid (TFA) at 60ºC and where the oxidation was achieved by 
adding 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) or p-chloranil.49 After almost 6 
years, Rocha Gonsalves and his collaborators proposed another method where the 
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condensation of pyrrole and aldehyde were done in refluxing acetic or propionic acid and in 
the presence of nitrobenzene for 1 h. These oxidative conditions solved the problem of 
porphyrins being contaminated with the correspondent chlorin.51 
In the Lindsey methodology (Scheme 5), the first step consisted in the condensation 
of pyrrole and aldehyde in dry CH2Cl2 in the presence of an acid catalyst (BF3, TFA or BCl3) 
at room temperature under nitrogen atmosphere and protected by light for 30-60 min. The 
second step involved the oxidation of porphyrinogen by adding an oxidant agent, like DDQ 
or p-chloranil, resulting in the correspondent porphyrin. With these conditions, TPP is 
obtained with an yield of 20%.52 
 
Scheme 5. Lindsey method for synthesis of 5,10,15,20-tetraphenylporphyrin (TPP). 
 
Although the Lindsey method allowed the synthesis of porphyrins with good yields 
from sensible aldehydes in acidic conditions, the reaction requires an elevated dilution, 
which implicates large volumes of solvent. Therefore, this method becomes less viable when 
synthetizing in a high scale. Furthermore, the utilization of high quantities of oxidizing 
agents leads to an inviable reaction purification.53 
The synthesis of N-confused porphyrin can be accomplished by methodologies which 
are similar to the ones described for porphyrins:  
a) Condensation of pyrrole and aldehyde54,55 
b) Condensation of “building-blocks”56,57 
Given that in this work all porphyrins derivatives were synthetized by condensation 
between pyrrole and aldehyde, only this methodology will be emphasized.  
The first studies involving N-confused porphyrins were reported in an independent 
way by Furuta10 and Latos-Granzinsky58 in 1994 (Scheme 6). In both cases, the method used 
to synthetize N-confused tetraarylporphyrin was an adaptation of the Lindsey methodology 
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to prepare porphyrins. That methodology consisted in the condensation between a pyrrole 
and the adequate aldehyde under catalytic acidic conditions followed by an oxidation step. 
Furuta selected HBr as the acid catalyst while Latos-Granzynski selected BF3.Et2O, but in 
both cases p-chloranil was used as the oxidizing agent. In these reactions the N-confused 
porphyrin was obtained with a yield of 5% and it was considered a by-product of the regular 
porphyrin synthesis.58 
In 1999, Lindsey described the preparation of NCTPP using as catalyst BF3.Et2O or 
TFA and DDQ as oxidizing agent.54 Later, Lindsey did the same reaction using 
methanesulfonic acid (MSA) as catalyst (Scheme 6). With this modification, Lindsey 
obtained a much better yield (39%) comparatively with all methods described until then but 
still obtained TPP (5% yield) as a by-product.55 This reactional conditions are the basis for 
preparing the N-confused porphyrin in the present work (Scheme 6, condition 4).  
 
Scheme 6. Synthesis of NCTPP according to Furuta (1), Latos-Granzynski (2) and Lindsey( 3 and 4).10,54,55,58 
 
 The literature yields of the N-confused porphyrin obtained from the condensation of 
pyrrole with benzaldehyde under different reaction conditions discussed above are 
summarized in Table 1  
 
 
 
 
 
  Chapter 1 
University of Aveiro   17 
Table 1. Reactional conditions for synthesizing N-confused porphyrins and their respective yields. 
Reactional conditions Yield 
TPP NCTPP 
1-a). HBr, 48 h room temperature; b) p-chloranil 20% 5-7% 
2-a) CH2Cl2, BF3OEt2, room temperature; b) p-
chloranil 
 4% (less than 
1% of the 
crude) 
3-a) CH2Cl2, BF3OEt2 or TFA room temperature; 
b) DDQ 
32% 7.5% 
4-a) CH2Cl2, MSA, room temperature; 30 min b) 
DDQ 5 min 
5% 39% 
 
 
1.1.6 Applications  
Tetrapyrrolic macrocycles are present in many forms in Nature with important roles 
as it was already mentioned before. Due to their biological, photophysical and 
photochemical properties, tetrapyrrolic macrocycles can also be applied in areas such as 
catalysis,59 artificial oxygen transporter,60 biomimetic models,61 sensors,62 semiconductors 
and superconductors.63 However, Medicine is the most relevant area where this type of 
compounds is being used, namely in photodynamic therapy (PDT)64 and in diagnostic field.65  
Nowadays tetrapyrrolic macrocycles are also being considered as intercalating agents 
of desoxyribonucleic acid (DNA).66 It is known that some DNA damaging agents (neoplastic 
therapeutic drugs) can affect alternative splicing (AS) as it will be shown later.67  
 
 
1.1.7 Photodynamic process 
Nowadays, cancer is one of the main causes of death in the world. Despite of 
numerous existing treatment, there are many secondary effects and disadvantages associated 
with it and sometimes these treatments do not even work. Therefore, it is required to find 
different and more efficient approaches. Porphyrins and their derivatives shown a 
photosensitizing ability in photodynamic therapy (PDT), making these macrocycles suitable 
candidates for this type of cancer therapy.68–70 
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PDT requires the combination of three different components: a photosensitizer (PS), 
light and molecular oxygen. The association of these components allows the generation of 
highly reactive oxygen species (ROS) which when in contact with cells can induce cell death 
or cause cell damage.64 One of those ROS species is singlet oxygen 1O2. (Figure 10) 
Therefore, the efficiency of the photodynamic process is dependent on the presence of 
molecular oxygen and on the way that the PS transfers the energy from its triplet state to O2 
in fundamental triplet energy state.  
 
Figure 10. Principle of the photodynamic therapy (PDT) process.  
 
The mechanism involved in PDT process can be explained by using a modified 
Jablonski’s diagram (Figure 11). This illustrates the several transitions that an electron can 
suffer after light absorption and transition to an excited state. 
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Figure 11. Modified Jablonski’s diagram. 
 
When a photosensitizer is irradiated with light, it is excited and transits from a 
fundamental state (S0) to a more excited singlet state (S2 or S3). This excited molecule has a 
short lifetime.71 
The PS transits to an excited singlet state with lower energy (S1) through internal 
conversion processes.72 After some nanoseconds this excited state tends to return to the 
ground state (S0). This transition can be done through three different processes: 
 Radiative decay with light emission, namely fluorescence emission with wavelength 
higher than the absorbed radiation.71  
 Non-radiative decay with release of heat.72,73 
 By intersystem crossing (ISC) where a spin inversion of the electron occurs. This 
inversion is quantum forbidden and the PS is transformed into an excited triplet state 
(T1). The decay to S0 can occur with phosphorescence emission and spin inversion 
again. However, being this transition forbidden, the photosensitizer reveals long 
lifetimes which allows the interaction with other molecules.12,71 
 
So, a good photosensitizer is the one that suffers intersystem crossing (ISC) with high 
efficiency. Given the long lifetime of the exited triplet state, this can interact with close 
molecules through two types of mechanism: type I and type II. 
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 Type I mechanism 
 In this mechanism, the abstraction of a hydrogen atom or the electron transference 
between the photosensitizer and a biological substrate is involved and it results in the 
formation of free radicals.18,71,73 
 
Scheme 7. Type I mechanism reactions. 
The anionic photosensitizer can react with the molecular oxygen O2 and generate the 
superoxide anion (O2
.-).34,71,74 The superoxide anion radical is not particularly reactive in 
biological systems but when protonated (Scheme 7- (4)) can produce hydrogen peroxide and 
molecular oxygen (Scheme 7-(5)) or highly reactive hydroxyl radicals. This hydrogen 
peroxide is highly toxic and can be removed by catalases.71 
 
Type II mechanism 
This type of mechanism is less complex and involves the formation of a reduced 
number of products when compared with the previous mechanism. In mechanism type II, 
the photosensitizer in its triplet state can transfer the energy in excess to the molecular 
oxygen in the ground state (3O2), relaxing to its ground state and producing singlet oxygen 
(1O2).
71 
The 1O2 is a high reactive oxygen species and despite of its short lifetime in the 
biological systems, it is considered the principle mediator of photochemical damage caused 
to cells by several photosensitizers. This 1O2 can interact with several enzymes leading to 
the inhibition of protein synthesis and modification of several DNA chains. This change 
leads to an alteration in the transcription and the replication process which can lead to cell 
death.  Even the unsaturated lipids can be a target to this triplet oxygen.71 
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There are several authors reporting photodynamic effect using tetrapyrrolic 
macrocycles68,75,76, being the most interesting to this work the 5,10,15,20-tetrakis(1-
methylpyridinium-4-yl)porphyrin TMPyP.69,77,78 
 
 
1.2 PDT and alternative splicing 
1.2.1 General background 
1.2.1.1 Photodynamic therapy as a new alternative to cancer treatment 
Photodynamic therapy is a clinically approved therapy which overlap to the orthodox 
ones for being minimally invasive and targeting only the malignant cells. It is used 
successfully for neoplastic and non-malignant diseases.79 
As it was said before, PDT consists of three essential components: PS, light and 
oxygen.64 The combination of these components can generate singlet oxygen that it is toxic 
to the cells and can cause their death through apoptosis, necrosis or autophagy. PDT involves 
two steps: administration of a light sensitive PS and the irradiation of the tumour location by 
light with appropriate wavelength. The main characteristic of photosensitizers in PDT is its 
high selectivity to localize in a neoplasm instead of the healthy cells. This can also be a 
disadvantage because this treatment cannot be applied to metastatic lesions which is the most 
frequent cause of death in cancer patients. It is important that the PS do not accumulate in 
the cell nucleus, leading to resistant clones or by limiting DNA damage that can be 
carcinogenic.64,79 
PDT has been recently used to treat several types of cancer such as skin tumours, 
digestive system tumours, prostate cancer and brain tumours. 64 
 
 
1.2.1.2 The photosensitizers 
There are several main characteristics that made certain compounds suitable for PS 
in PDT. A PS should be stable in storage and not have dark toxicity, having a rapid 
pharmacokinetic elimination.80 These compounds have to ideally absorb light in the red or 
far-red in order to penetrate the tissues. The high absorption peak must be between 600 and 
800 nm because if it is longer than 800 nm, there is not enough energy to excite the molecular 
oxygen to its singlet state.64 The PS should not aggregate under biological conditions 
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because it diminishes its capacity of absorbing light and consequently its photochemical 
efficiency to generate singlet oxygen.80 
It is important to highlight that the synthesis of the desirable PS should be cheap, 
easy and the starting materials available to make large-scale production or in some cases the 
PS can be commercial available. It is better for the photosensitizers to be water-soluble 
because they can easily travel in the body. When insoluble in water, the PS should be 
incorporated in liposomes or in an emulsion.64,80,81 
There are many photosensitizers used in PDT. Among them there are the ones with 
tetrapyrrolic core 80 such as chlorins,81 phtalocyanines and porphyrins.82 The first and the 
most widely used photosensitizer employed in cancer was a mixture of porphyrins called 
purified hematoporphyrin derivative, usually known as Photofrin®.64 This shows that 
tetrapyrrolic macrocycles are very studied for PDT application and that porphyrins 
derivatives can be promising as PS. 
 
 
1.2.1.3 Subcellular localization 
The precise cellular localization of a PS is very important because ROS act close to 
its site generation and depending on the location, there is a difference in the damage caused 
to the cell. So, the study of the PS localization is useful in order to select the correct PS 
according to the desired application. There are several structural characteristics that 
determine the intracellular distribution such as the net ionic charge (can vary from -4 to +4), 
the degree of asymmetry of the molecule and the degree of hydrophobicity. 
The easiest way to detect the intracellular location of a PS is by confocal laser 
scanning fluorescence microscopy. This technique is more sensible and has a better special 
resolution than non-confocal techniques.80,83,84 
 
 
1.2.1.4 Effects of PDT and Immune Response 
PDT causes, sometimes, a strong acute inflammatory reaction at the target site which 
is triggered by the oxidative stress induced by PDT. The tumour vasculature is changed and 
the inflammatory cells (neutrophils/macrophages followed by mast cells and 
monocytes/macrophages) rapidly invade tumours going through PDT. The damage in the 
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treated tumour makes its vasculature to block the tumour tissue preventing it from spreading 
the disrupted homeostasis until these cells are eliminated by the white cells. It was shown 
that if these blood cells were depleted, the effect of PDT is diminished.64 
 
 
1.2.2 Cell Death: apoptosis, necrosis and autophagy 
PDT can induce three different pathways of cell death: apoptosis, necrosis and 
autophagy. The first is the most found in cells which underwent PDT. However, if the cells 
have deficient caspases (see later), the cells undergo necrosis. On the other hand, it was 
reported recently that the cells can undergo autophagy to preserve cell viability after 
photodynamic injury.64 
 
Necrosis 
This type of death results from enzymatic digestion of the injured cells. The 
membrane integrity is often affected and the necrotic cell contents leak out. The enzymes 
which digest these cells are derived from its lysosomes or from the white cells’ lysosomes 
that take part in the inflammatory reaction.85 
This type of cell death is often observed due to a response to severe stress as physical 
injury or long periods of ischemia (reduced blood flow which leads to a decrease in oxygen 
and nutrients). It was thought that necrosis was not a regulated process. However, there are 
evidence that this type of cell can be regulated (in that case called necroptosis), occurring as 
an alternative to apoptosis.86 
 
Necroptosis 
This type of death is known to be the regulated necrosis and it occurs often in cells 
in which the normal apoptotic pathway is blocked or deficient. Necroptosis is often 
associated with depletion of ATP which can lead to an increase in Ca2+ concentration which, 
in turn, can induce the activation of calpains (protease). These enzymes can lead to lysosomal 
rupture and release of another enzymes that can destruct the cells.86,87 
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Apoptosis 
Apoptosis (Figure 12) is a type of programmed cell death with a tightly regulated 
pathway in which cells that are designated to die activate enzymes that degrades its own 
DNA and proteins. The apoptotic cells become apoptotic bodies that contain pieces of the 
cytoplasm and nucleus after disrupting into fragments. However, the plasma membrane stays 
intact but its structure is altered in a way that they become easy targets for phagocytes. These 
changings can include the movement of some phospholipids from the internal to the external 
membrane surface, where they are identified by phagocytes’ receptors. Besides this change, 
there is DNA breakdown and activation caspases, essential enzymes to the apoptotic 
pathway.85,86 
 
 
Figure 12. The apoptosis pathway. 
 
There are two different initiating pathways which converge to a cascade of caspase 
activation: the intrinsic (mitochondrial) pathway and the extrinsic (death receptor mediated) 
pathway. The first one is mediated by anti and pro-apoptotic family of proteins, called Bcl 
and is characterized by an increase in mitochondrial permeability. These proteins cause 
activation of another proteins which will cause the leakage to the cytoplasm of essential 
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proteins that can cleave caspase-9 (a critical initiator caspase) and initiate the caspase 
cascade. In the extrinsic pathway, membrane death receptors are involved. The name death 
receptors came from its role in the apoptotic pathway. In the initiation pathway, there is an 
activation of caspase-10 which triggers the cascade of caspases by cleaving and activating 
the thereby inactive caspases. The now active caspases will mediate the execution phase.87  
These two pathways have different molecules involved in the initiation phase and for 
that reason they were described in separated.  
As it was said before, the two initiation phases converge to a cascade of caspase 
activation which mediates the execution and final phase of the apoptosis. This involves 
caspase-3 which act in many cellular components that will lead to the several changes that 
were mentioned before. 
 
Autophagy 
Autophagy is a type of cell death that occur when there is nutrient deprivation and 
the cell eats its own contents in order to survive. In the beginning of this process, intracellular 
organelles are put in a autophagic vacuole that later will fuse with the lysosomes and become 
the autophagosome.85 
 
There are several ways to assess the type of cell death. For example, by doing a 
Western Blot in order to detect specific key proteins of apoptosis, necrosis, autophagy and 
necroptosis. In this work, this technique will be used and for that reason some considerations 
about it are made in chapter 4. 
 
 
1.2.3 The alternative splicing process 
It is known that eukaryotic genes contain introns which are segments of genes that 
do not code for polypeptides. The introns are removed from the primary transcript while the 
RNA molecule is still being synthesized before transportation into the cytoplasm. The 
removal of introns (non-coding regions) and the joining of the remaining exons (coding 
regions) is named splicing. This process is like a movie edition when a single part is cut and 
then the rest of the movie is re-joined together. The splicing process is conducted by the 
spliceosome, a large and dynamic ribonucleoproteic complex, regulated by the interaction 
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between cis-acting elements and over 200 trans-regulating proteins. The activity of the 
regulatory proteins depends of their intracellular localization, their post-translational 
modifications and binding to other proteins.  
 
Alternative splicing results in different mature mRNAs which in turn results in 
different protein isoforms which can have opposite functions88. This type of splicing can 
produce different mRNAs and different proteins from the same primary transcript. 
 
Modes of alternative Splicing 
Exons present in the expressed mature transcript are termed constitutive exons 
opposing to alternative exons which only appears in particularly transcripts. There are five 
possible  alternative splicing as shown in Figure 13.88 The most common is exon skipping 
where a selected exon is removed from the mature mRNA. 
 
Figure 13. Types of splicing. 88,89 
 
Alternative 3’ or 5’ splice site occurs when a partial sequence of an intron is included. 
There is also intron retention in which an intron remains in the mature mRNA and is the 
rarest alternative splicing event.90 At last, there is the mutually exclusive exons where the 
targeted exons  are never simultaneously in the same transcript.  
 
 
1.2.4 Alternative splicing and cancer 
Ninety-five percent of the pre-mRNA undergoes alternative splicing (AS). This 
process contributes largely to the diversity and the flexibility of the proteome compare to the 
genome. The isoforms generated from a single pre-mRNA often have modified functions 
and in some instance opposite functions. 
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Given that alternative splicing controls several essential processes like cell division 
and differentiation, alteration on this process can lead to many diseases such as cancer. It is 
known that many oncogenes and tumour suppressors are alternatively spliced in cancer. p53 
known to be inactivated in cancer, functions as a transcription factor and is responsible for 
maintain the genetic stability.88 p53 has 9 different isoforms that result from alternative 
splicing. Several isoforms are known to be associated with loss of p53 function and cancer. 
In case of the splicing factor SRSF1 which can act as proto-oncogene and its overexpression 
can result in tumour formation. However, RBM4 (another splicing factor) was found to have 
tumour suppressor function unlike other splicing factors.88,91,92 
With the recognition of the role for pre-mRNA splicing  in cancer, there is an attempt 
to understand how this contributes to anticancer drug resistance. The aberrant pre-mRNA 
splicing can promote cell survival in response to chemotherapy by dysregulation of the 
apoptosis process.88,92–94  
The regulation of apoptosis depends on the pro and anti-apoptotic factors, which in 
turned can result in a decrease on drug sensitivity. There are many genes involved in 
apoptosis which are regulated by alternative splicing. Bcl-x when alternative spliced forms 
two isoforms: the anti-apoptotic Bcl-xL and the pro-apoptotic Bcl-xS (as mentioned above). 
Cancer cells have elevated expression of the Bcl-xL which results in apoptosis inhibition. 
Also, caspase-2S (anti-apoptotic) has high expression in cancer cells and it enhances survival 
of this cells.88,94,95 
 Alteration in splicing of genes involved in pro-drug activation can lead to resistance 
of specific chemotherapeutics. 
 Giving all of this, different therapies are being developed to target splicing 
aberrations like inhibitors of the spliceosome or oligonucleotides.88 
 
 
1.3  Aim of Work 
It is known that the most common drugs used in chemotherapy (like cisplatin, 
doxorubicin and oxaliplatin) have been losing their efficiency due to a mechanism of DNA 
damage repair of cells creating a drug resistance. These mechanisms can repair the 
monoadducts and intra-strand cross links induced by platinum-based compounds with 
DNA.96,97 More recently, over 600 cisplatin-related AS events in MCF-7 (breast cancer cell 
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line) cells were identified and observed that the reduction of AS led to a reduction of the 
stress related apoptosis.93 
PDT relies on a photosensitiser that accumulates in tumour cells and is activated by 
visible light, which leads throughout an oxidative stress to cell death by apoptosis and 
necrosis.64 It was shown that are different tetrapyrrolic macrocycles used effectively in PDT 
namely porphyrins, chlorins, among others. Having in mind that PDT and AS of mRNA can 
cause cell death, the final aim of this work was to study the effect of PDT using porphyrinic 
PS on alternative splicing of mRNA. Thus, a set of cationic porphyrin derivatives 
[5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)porphyrin and 5,10,15,20-
tetrakis(4-(pyridinium-1-yl-methyl)phenyl)-2-aza-21-carbaporphyrin] were prepared and 
their biological properties compared with 5,10,15,20-tetrakis(1-methylpyridinium-4-
yl)porphyrin which is known to be a good PS. Considering that AS can origin several protein 
isoforms which can lead to a specific type of cell death, it is important to study which cell 
type of death the cells undergo after PDT treatment and to study its effect on alternative 
splicing of mRNA. 
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2.1 N-Confused-porphyrin and porphyrin synthesis 
2.1.1 General remarks 
As it was mentioned in the previous chapter, it is known that cationic porphyrins 
are promising photosensitizers in PDT. One of the most studied cationic porphyrin is 
5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin (TMPyP) (Figure 14) due to 
their good properties for PDT.98,99 Based on TMPyP structure and knowing that N-
confused porphyrins recently discovered, possess interesting photosensitizing 
properties,100,101 it seemed attractive to design a N-confused porphyrin considering 
TMPyP structure. So, our first target was to evaluate the possibility to synthesise the 
5,10,15,20-tetrakis(pyridyl-4-yl)-2-aza-21-carbaporphyrin (H2TPyNCPP) (see Scheme 
8).  
 
 
Figure 14. Structure of 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin (TMPyP). 
 
The synthetic strategy to prepare H2TPyNCPP was based on Lindsey 
methodology, considering that it is the most efficient one to prepare N-confused 
porphyrins.55 The first step involved the condensation between pyrrole and 4-
pyridinecarboxaldehyde in CH2Cl2, using a catalytic amount of MSA, at room 
temperature for 30 min. After this period DDQ was added and the reaction was stirred for 
1 min. The oxidation step was followed by TLC which showed the formation of a less 
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polar compound than it was expected to obtain; in general N-confused porphyrins are 
more polar than regular porphyrins. 
 
Scheme 8. Synthesis of H2TPyP under Lindsey conditions. 
 
After the reaction purification by column chromatography, using as eluent a 
mixture of CH2Cl2/MeOH (3%), two main fractions were obtained although only one 
showed a UV-Vis spectrum with Soret and Q bands, typical of a porphyrin derivative. 
This polar fraction was posteriorly identified by TLC as being constituted by the regular 
H2TPyP. 
So, the synthesis of the N-confused H2TPyNCP was not successful and instead it 
was isolated H2TPyP but in small amount. Probably, the high oxidant environment 
required by the Lindsey conditions for this aldehyde, in the second step is not ideal to 
generate H2TPyNCP.  
These results prompt us to try the synthesis of the N-confused cationic porphyrin 
5,10,15,20-tetrakis(-(piridinium-1-yl-methyl)phenyl)-2-aza-21-carbaporphyrin 
tetrabromide salt (2, X = Br) (Figure 15-right) reported by Ikawa and co-workers. 102 
These authors were able to prepare the N-confused porphyrin 2 by introducing cationic 
side-arms at the meso-positions of 5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-
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carbaporphyrin (1) (Figure 15- left).102 So, porphyrin 2 (X = I) and the correspondent  
cationic regular porphyrin 5,10,15,20-tetrakis(4-(pyridinium-1-yl-
methyl)phenyl)porphyrin tetraiodide were the ones selected to be prepared in this work. 
In the next sections a detailed description of the experimental work performed concerning 
the synthesis of these two derivatives it is discussed.  
 
Figure 15. Structure of 1 and of its cationic derivative 2. 
 
 
2.1.2 Synthesis of the precursors 5,10,15,20-tetrakis(4-
bromomethylphenyl)-2-aza-21-carbaporphyrin and 5,10,15,20-
tetrakis(4-bromomethylphenyl)porphyrin  
In order to prepare the desired porphyrinic derivatives 5,10,15,20-tetrakis(4-
bromomethylphenyl)-2-aza-21-carbaporphyrin (1) and 5,10,15,20-tetrakis(4-
bromomethylphenyl)porphyrin (5) (Scheme 9), it was necessary first to prepare the 4-
bromomethylbenzaldehyde 4.  
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Scheme 9. Synthesis of 5,10,15,20-tetrakis(4-bromomethylphenyl)porphyrin 5 and 5,10,15,20-tetrakis(4-
bromomethylphenyl)-2-aza-21-carbapophyrin 1. 
 
According to literature this aldehyde can be obtained by oxidation of 1,4-
bis(bromomethyl)benzene 3 using manganese oxide(IV) (Scheme 10).103 The reaction 
was carried out in refluxing CHCl3 using 4.6 equivalents of MnO2. After 72 h, the reaction 
mixture was filtered through a celite column and then it was purified by column 
chromatography using a mixture of hexane/CH2Cl2 (1:1) as eluent. In this purification 
process was isolated two main fractions; the less polar one corresponded to the starting 
compound 3 (confirmed by TLC and 1H NMR) and the more polar one it was identified 
as being the desired compound 4. This derivative was isolated in 19% yield and its 
structure was confirmed by 1H NMR and mass spectroscopy.  
 
 
Scheme 10. Oxidation of 1,4-bis(bromomethyl)benzene 3 into 4-bromomethylbenzaldehyde 4 
 
The 1H NMR spectrum of compound 4 (Figure 16) shows a typical spectrum of a 
para-substituted aromatic system with two doublets and two singlets. The characteristic 
singlet at δ 10.02 ppm corresponds to the resonance of the carbonyl proton (-CHO) and 
the two doublets at δ 7.56 and δ 7.87 ppm (J = 8.2 Hz) are due to the aromatic protons H-
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2,6 and H-3,5. The resonances due to the aliphatic protons CH2 appear as a singlet at 4.52 
ppm.  
In the mass spectrometry analysis [ESI]+, a peak at m/z 199.0 corresponding to 
[M+H]+ ion of compound 4, allowed also to confirm its structure.  
 
 
Figure 16.  1H NMR spectrum of compound 4 (300MHz, CDCl3). 
 
The condensation of the synthesised 4-bromomethylbenzaldehyde 4 with pyrrole, 
in order to obtain 5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-carbaporphyrin 
(1) (Scheme 9) was performed according to Lindsey conditions.102 This condensation was 
performed in CH2Cl2 in the presence of MSA and under nitrogen atmosphere at room 
temperature. The reaction was stirred for 30 min and after this period DDQ was added to 
promote the oxidation; the TLC control shown the formation of two main compounds.  
Then, the mixture was purified by preparative TLC using a mixture of CH2Cl2/CH3OH 
(92:8) as eluent. The first fraction with a reddish colour was identified as being the regular 
porphyrin 5 and was isolated in 23% yield; the second fraction, with a dark green colour, 
showed to be the N-confused porphyrin 1 and was obtained in 9% yield (Scheme 9). 
The structure of both compounds was confirmed by spectroscopic data namely 1H 
NMR and mass spectrometry.  
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The analysis of the 1H NMR spectrum of compound 5 (Figure 17) confirms as 
expected, the presence of a highly symmetric structure and the singlet that appear at δ -
2.82 ppm corresponds to the resonance of the two N-H protons of the porphyrin inner 
core. 
 
 
Figure 17. 1H NMR spectrum of porphyrin 5 (300MHz, CDCl3). 
 
These protons are highly protected due to the anisotropic effect induced by the 
electron delocalization of the macrocycle. Still in the aliphatic region it is possible to 
observe a singlet at δ 4.86 ppm which corresponds to the resonance of the four -CH2 
protons. Regarding the aromatic region, it is possible to observe three different signals. 
Two doublets at δ 7.80 and δ 8.19 ppm with a coupling constant of J = 8.1 Hz due to the 
resonance of the protons H-3', 5' and proton H-2', 6', respectively, and a singlet at δ 8.84 
ppm generated by the resonance of the β-pyrrolic protons.  
The ESI mass spectrum of compound 5 corroborated also the structure proposed, 
showing the peak of [M+H]+ ion at m/z 987.1.  
As it was mentioned above, the structure of the more polar compound was 
identified by 1H NMR (Figure 18) and mass spectroscopy techniques as being the N-
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confused derivative 1. The 1H NMR spectrum is representative of a compound with a 
much less symmetric structure than 5.  
 
 
Figure 18. 1H NMR spectrum of porphyrin 1 (300MHz, CDCl3). 
 
It was very difficult to obtain a 1H NMR spectrum with well defined peaks because 
derivative 1 is very unstable during the purification work-up probably due to some self-
polymerization. However, it is possible to detect a broad singlet at δ -5.0 ppm which 
corresponds to the resonance of the highly protected C-H inner core. Still in the aliphatic 
region at δ 4.82 and δ 4.84 ppm it is possible to observe two singlets that correspond to 
the resonance of the 4 -CH2 protons. In the aromatic area it is possible to observe the 
signals corresponding to the resonance of the β-pyrrolic protons: two doublets at δ 8.95 
ppm (J = 4.7 Hz) and δ 9.0 ppm ( J = 5.1 Hz) and one multiplet between δ 8.50 and 8.65 
ppm; in this region it is still possible to observe the signals corresponding to the orto and 
meta protons of the para-substituted phenyl rings: a multiplet at δ 8.22-8.36 ppm and 
another at δ  8.11-8.15 ppm; a doublet at δ 7.80 ppm ( J = 9.2 Hz) and a multiplet between 
δ 7.87 ppm and δ 7.91 ppm, respectively. This 1H NMR spectrum is consistent with the 
one already described in the literature.102 
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The structure of compound 1 was also confirmed by the ESI(+) mass spectrum 
which revealed a peak at m/z 987.1 corresponding to the [M+H]+ ion.  
 
 
2.1.3 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-
methyl)phenyl)porphyrin tetraiodide (6) and 5,10,15,20-tetrakis(4-
(pyridinium-1-yl-methyl)phenyl)-2-aza-21-carbaporphyrin 
tetraiodide (2)  
The synthetic approach to obtain the cationic porphyrins 1 and 5 (Scheme 11), 
was based on the nucleophilic substitution of the bromine atoms in the meso-aryl groups 
by pyridine. In contrast with the described procedure102 it was added sodium iodide (NaI) 
in order to favour the nucleophilic substitution.  
 
Scheme 11. Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)-2-aza-21-carbaporphyrin 
tetraiodide (2) and 5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)porphyrin tetraiodide (6) 
 
 Therefore, both cationic porphyrins were prepared by adding 6.0 equivalents of 
NaI to the appropriate porphyrin derivative (1 or 5) in pyridine at room temperature. After 
30 min, the formation of the cationic N-confused porphyrin 2 was confirmed by TLC and 
after the work up, the desired porphyrin was isolated in 82% yield. Porphyrin 6 was 
obtained in 90% yield from the regular porphyrin 5 after 5 min of reaction.  
The structure of both compounds was confirmed by 1H NMR and mass spectroscopy 
(Figure 19, Figure 20 and Figure 21). 
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Figure 19. 1H NMR spectrum of porphyrin 6 (300MHz, DMSO-d6). 
 
The insertion of the pyridinium group in porphyrin 5 induced some changes in the 
1H NMR spectrum of 6. This introduction leads to the shift of the -CH2 resonance singlet 
to low field region of the spectrum, appearing now at δ 6.25 ppm. These protons become 
more unshielded due the new pyridinium moiety linked to the -CH2 carbon by the nitrogen 
atom. The signals corresponding to the protons of the pyridinium group H-2''', 6''' appear 
as a doublet at 9.51 ppm (J = 5.6 Hz) being these the most unshielded proton of the 
pyridinium ring due the proximity of the positive charged heteroatom. The other protons 
corresponding to H- 3''',5''' resonate as a doublet of doublets at δ 8.37 ppm (J1 = 6.7 Hz 
and J2 = 7.8 Hz) because it couples differently with H-2''',6''' and H-4'''. The identification 
of the protons of the pyridinium moiety was confirmed by 2D spectra (see Figure 20). 
These experiments allowed to verify that the signal corresponding to protons H-4''' 
appears overlapped with the multiplet generated by the β-pyrrolic protons between δ 8.76 
ppm and δ 8.80 ppm. As expected the resonance of the two protons in the inner core of 
the porphyrinic macrocycle appear as a singlet at δ -3.0 ppm. The 2D experiments 
(COSY, HSQC and HMBC) allowed also to identify some carbons (see experimental 
part).  
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Figure 20. Expansion of COSY (A), HSQC (B) and HMBC (C) spectra of porphyrin 6 in DMSO-d6 (500 MHz). 
 
The ESI(+) mass spectrum for compound 6 shows a peak at m/z 245.9 
corresponding to [M]4+ ion. Also, the presence of two peaks at m/z 225.6 and m/z 274.5 
corresponding to [M-Py-H]4+ and [M-2Py-2H]3+, respectively, helped to confirm the 
structure of compound 6. 
 Considering the identification of compound 2 by NMR, it was very difficult to 
acquire a good spectrum even after trying different conditions. The best spectrum was 
obtained in DMSO at 50ºC, although the quality was not very good (Figure 21). 
However, the signals in the 1H NMR spectrum are in accordance with the literature for 
this compound102 and it was possible to detect the deviation of the multiplet due to the 
CH2 resonance to δ 6.12-6.23; the signals corresponding to the H-pyridinium units were 
also detected at δ 8.74 ppm, δ 8.30-8.34 ppm and δ 9.40-9.49 ppm. 
C 
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Figure 21. 1H NMR spectrum of porphyrin 2 (300MHz, DMSO-d6 at 50ºC). 
 
The mass spectrum of compound 2 in ESI (+) shown two peaks at m/z 274.5 and 
at m/z 225.8 which corresponds to [M-2Py-H]3+ and [M-Py-H]4+ ions, respectively. 
 
 
2.2 Photophysical Characterization 
In order to know the effect of the insertion of the pyridinium groups in   the 
photophysical properties of compounds 2 and 6, their coefficients of absorptivity molar 
(ε) and the fluorescence quantum yields were compared with the ones of compounds 1 
and 5. In Figure 22 are shown the absorption spectra of all porphyrins recorded in DMF 
and the coefficient of absorptivity molar of each band is summarized in Table 2.  The 
UV-Vis spectrum of the regular porphyrin 5 (Figure 22) shows a typical ethio-type 
spectrum with a strong Soret band at 419 nm and four Q bands between 516 and 647 nm. 
No significant changes were detected in the UV-Vis spectrum of the cationic porphyrin 6 
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when compared with its neutral precursor 5; the Soret band is also localized at 419 nm 
and the Q bands appear between 515 and 647 nm (Figure 22). 
 
Figure 22. Normalized UV-Vis spectra in DMF of porphyrin 1, 2, 5 and 6. 
 
The inversion of one pyrrole ring change the macrocycle conjugation and the 
absorption properties of compounds 1 and 2 were strongly affected when compared with 
the ones of the regular porphyrins (Figure 22 and Table 2). Therefore, for compound 1 
it is possible to observe a red-shifted spectrum with the Soret band at 445 nm and the four  
Q bands between 548 and 705 nm. The UV-Vis spectrum of porphyrin 2 shows also the 
spectrum of a typical N-confused derivative but the Soret band suffered a red-shift of 8 
nm when compared with the one of the neutral porphyrin 1. In the Q band region, it was 
observed a small blue-shift (15 nm) for the last Q band, but no significant changes were 
observed for the remaining bands.  
The emission spectrum of each compound was also performed in DMF and it was 
measured under normal conditions (open air) at 298 K. The fluorescence quantum yield 
(ΦFlu) of each porphyrin was calculated by using a fluorescence standard and was made 
through the formula:  
𝛷𝐹𝑙𝑢 = 𝛷𝑆𝑡
𝜂2
𝜂𝑆𝑡
2
𝐼
𝐴
𝐴𝑆𝑡
𝐼𝑆𝑡
 
where ΦSt is the fluorescence quantum yield of the standard compound, η is the 
refractive index of the solvent, I is the integrated fluorescence intensity (area underneath 
the spectrum) and A is the absorbance at the excitation wavelength λ= 425 nm. In this 
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work, the standard reference used was TPP in DMF (ΦFlu = 0.11).104 The absorbance of 
each compound at 425 nm was kept between 0.0414-0.0540 in order to avoid inner filter 
effects and ensure linear response on the fluorescence intensity.  
The studied compounds shown different emission profile. The N-confused 
porphyrin derivatives 1 and 2 did not show any fluorescence emission in DMF while 
porphyrins 5 and 6 have an emission spectrum characteristic of porphyrins (Figure 23). 
The spectra of 5 and 6 are characterized by a strong emission band with a maximum 
intensity around 650 nm and a less strong band at 715 nm (Figure 23). The fluorescence 
quantum yield obtained is similar for both porphyrins (Table 2) and to the reference TPP 
(0.11); it is worth to refer that the fluorescence emission was not significantly affected by 
the insertion of the pyridine units.  
 
Table 2. Photophysical parameters of porphyrins 1, 2, 5 and 6 in DMF. The fluorescence parameters 
of TMPyP were done in DMF and the others were done in DMSO.105  
Photophysical properties 1 2 5 6 TMPyP 
Soret and Q bands (log (ε)) 
445 (4.96) 453 (4.92) 419 (5.87) 419 (5.63) 425 (5.43) 
548 (3.91) 549 (3.79) 516 (4.42) 515 (4.49) 516 (4.29) 
595 (3.95) 598 (3.89) 551 (4.15) 551 (4.16) 549 (3.77) 
646 (3.96) 643 (3.90) 592 (3.90) 590 (3.96) 588 (3.84) 
705 (3.98) 690 (3.93) 647 (3.85) 647 (3.87) 642 (3.30) 
λem (nm) -- -- 652, 717 651, 716 652, 714 
ΦFlu -- -- 0.11 0.10 0.12 
 
Concerning the N-confused derivatives, it is reported in the literature a very low 
fluorescence emission for 5,10,15,20-tetraphenyl-2-aza-21-carbaporphyrin (ΦFlu =0.036 
– 0.0016)  and it is dependent on which is the preferential tautomer (see chapter 1, Scheme 
1). So, the results obtained for these derivatives are in accordance with the ones described 
in the literature.106,107 
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Figure 23. Normalized UV-Vis and normalized fluorescence spectra of porphyrin 1, 2, 5 and 6 with λexc= 424 
nm and OD = 0.05 in DMF. 
 
Since the main aim of this work was to evaluate the ability of the synthesized 
compounds to act as  photosensitizers and also to assess their influence on alternative 
splicing, it was important first to study their capacity to generate singlet oxygen.108 
The method used in this work to determine the 1O2 generation involves the 1,3-
diphenylisobenzofuran quencher (DPiBF). DPiBF is a furan and can be used to 
qualitatively determine the 1O2 generation. This compound absorbs in the visible region 
of the spectrum, namely at 415 nm. However, in the presence of 1O2, the DPiBF 
undergoes a cycloaddition [4+2] with 1O2 and it is converted into an intermediate 7 which 
is subsequently degraded in 1,2-dibenzoylbenzene (1,2-DBB) (Figure 24). As the 1,2-
DBB formed does not absorb in the visible region of the electromagnetic spectrum, a 
decrease in the absorbance of a DPiBF solution allows to evaluate the amount of 1O2 
produced by the porphyrinic derivative in study. Thus, this reaction was the base to 
perform a qualitative test to determine if the previous synthesized derivatives and 
potential PSs can generate 1O2 when activated by light. 
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Figure 24. Degradation of the DPiBF in 1,2-DBB in the presence of 1O2. 
 
In order to determine qualitatively the production of 1O2, the PS and the DPiBF 
are dissolved in a solvent which does not interfere with the 1O2 generation and its 
quantification. The concentration of the DPiBF must be about 100 times higher than the 
PS concentration because the PS also absorbs in the visible region where it was monitored 
the DPiBF degradation. If the photosensitizer is able to generate 1O2, by illuminating the 
solution with light above 550 nm, a decreasing in absorbance of the DPiBF will happen. 
The DPiBF absorbance monitoring is done at 415 nm. The results enable us to correlate 
the absorbance of the DPiBF with the 1O2 production.  
In a quartz cuvette, a solution with a PS concentration of 0.5 and 50 µM of DPiBF 
in DMF was prepared. The solution was irradiated with a light of wavelength 640 ± 20 
nm and with an irradiance of 9 mW/cm2 and the absorbance was measured. The neutral 
TPP and the cationic TMPyP were selected as controls because it is known that they are 
good photosensitizers.68 
Since the reaction of DPiBF with 1O2 follows a first order kinetics, the [
1O2] is 
proportional to 𝐿𝑛
𝐴0𝐷𝑃𝑖𝐵𝐹
𝐴𝐷𝑃𝑖𝐵𝐹
, where A is the absorbance of DPiBF in each minute and A0 
the initial absorbance of the DPiBF.   
The results obtained for neutral (1 and 5) and cationic (2 and 6) porphyrinic 
derivatives (Figure 26) are represented in Figure 25 and Figure 26. Structure of 
porphyrin 1, 2, 5, 6, TPP and TMPyP. 
 
Table 3. The decay of DPiBF absorbance in the presence of each compound 
confirms that only the regular porphyrins have high efficiency to generate 1O2. 
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Figure 25. Comparative degradation of DPiBF (50µM) in DMF for 10 min with or without photosensitiser (0.5 
µM); red light (9mW/cm2).  
 
 
Figure 26. Structure of porphyrin 1, 2, 5, 6, TPP and TMPyP. 
 
Table 3. Slopes of the degradation of DPiBF (50 µM) in DMF for 10 min with or without photosensitizer (0.5 
µM ) by using red light (9mW/cm2 ) 
COMPOUND SPLOPE 
DPIBF 1.67 × 10−4 
1 6.82 × 10−4 
2 2.33 × 10−4 
5 2.09 × 10−3 
6 1.52 × 10−3 
TPP 2.02 × 10−3 
TMPYP 6.36 × 10−4 
 
Regarding the synthesised derivatives, the regular porphyrin 5 is the best 1O2 
generator being slightly better than TPP, known as a good singlet oxygen generator (Φ 
= 0.65 in DMF). In contrast, the cationic N-confused derivative 2 does not show any 
ability to generate singlet oxygen. In fact, the DPiBF photodegradation in the presence 
of 2 is comparable to its own photodegradation in absence of a PS. On the other hand, 
regarding the cationic porphyrin derivative 6 is ability to produce 1O2 is much higher than 
the one of the well-known cationic PS TMPyP. However, the insertion of the pyridinium 
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moieties was responsible by a decrease in the ability of compound 6 to generate 1O2 when 
compared with porphyrin 5. As far as we know, there are no records in the literature 
regarding the ability of the compounds synthesised to generate singlet oxygen. However, 
it was reported that the meso-tetrakis(p-sulfonatophenyl)-N-confusedporphyrin 
tetrasodium salt was a highly efficient singlet oxygen generator.100 This seems to indicate 
that the singlet oxygen generation is dependent of the substituents in the meso positions. 
The results above mentioned indicate that among the synthesized porphyrins only 
5 and 6 shown to be good PS candidates.  
 
 
2.3  Material and methods  
2.3.1 Chemicals and equipment 
The commercial chemicals were used without any further purification and the 
solvents used in synthesis or purification process were analytical pure or distilled when 
needed. Pyridine was dried by refluxing it in the presence of adding sodium hydroxide 
and then distilled. 
The evolution of chemical reactions was controlled by analytical TLC carried out 
on precoated sheets with silica gel (Merck 60, 0.2 mm thick for coloured compounds and 
with F254 for uncoloured compounds). The compounds purification was done in general 
by column chromatography with silica gel 60 with 0.063-0.200 nm (Merck). The 
preparative thin layer chromatography purifications were performed in glass plates 
(20x20 cm), previous coated by a layer of silica gel 60 of Merck with 0.5 mm of thick 
and further activation at 100ºC for 12 h. All of the fractions were monitored by TLC and 
UV-Vis (between λ = 350 and λ = 800 nm). The Celite ® used for reaction purification 
was Celite® S (Sigma-Aldrich). 
The 1H NMR spectra were recorded in a Bruker AMX 300 NMR spectrometer at 
300.13 MHz. CDCl3 was used as a solvent but in some cases other solvents were used 
and that it is indicated. TMS was used as internal reference. The chemical shifts are 
expressed in δ (ppm) and the coupling constants (J) in Hertz (Hz). 
The electrospray ionization mass spectra (ESI+) were recorded in a mass 
spectrometer Q-TOF [1µg of sample was dissolved in chloroform or tetrahydrofuran 
(THF) in 200 µL of 0.1% of formic acid/methanol solution. Nitrogen was used as 
nebulization gas and argon as collision gas. The needle voltage was set to 3000 V with 
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an ion source of 80ºC and a desolvation temperature of 150ºC. The cone voltage was 35 
V]. The data obtained from the mass spectra are represented in mass/charge of the 
correspondent ions. These mass spectra were done by the mass spectroscopy group of the 
chemistry department of University of Aveiro. 
Absorption and fluorescence spectra were recorded in DMF using a Shimadzu 
UV-2501-PC and FluoroMax3 (in 1 cm × 1 cm quartz optical cells), respectively. As 
reference for measurements of fluorescence quantum yield, ΦFlu, the meso-
tetraphenylporphyrin (TPP) in DMF (ΦFlu =0.11) was used.104  
 
 
2.3.2 Synthesis of 4-bromomethylbenzaldehyde (4) 
Manganese oxide (IV) (2.25 g, 25.9 mmol) was added to a solution of 1,4-
bis(bromomethyl)benzene 3 (1.5 g, 5.6 mmol) in chloroform (18.0 mL) and the mixture 
was heated at reflux for 72 h. After this time the reaction mixture was filtered on Celite®. 
The crude material was taken into CH2Cl2 and directly chromatographed by silica column 
using hexane/CH2Cl2 (2:1) as eluent. The first fraction was identified as 3. The second 
fraction eluted with hexane/CH2Cl2 (1:1) gave the desired aldehyde 4 (212 mg,19%). 
 
 
1,4-bis(bromomethyl)benzene (3). Aspect: white solid. Yield: 28% (63.3 mg). 1H NMR 
(300 MHz, CDCl3): δ (ppm) 4.48 (s, 4H, -CH2); 7.57 (s, 4H, H-2,6 and H-
3,5) ppm. 
 
 
 
 
4-Bromomethylbenzaldehyde (4). Aspect: white crystals. Yield: 19% (212 mg). 1H 
NMR (300 MHz, CDCl3): δ (ppm) 4.52 (s, 2H, -CH2); 7.56 (d, 2H, J = 
8.2 Hz, H-3,5); 7.87 (d, 2H, J = 8.2 Hz, H-2,6); 10.02 (s, 1H, CHO) . MS 
(ESI (+)): m/z 199 [M+H]+.  
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2.3.3 Synthesis of 5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-
carbaporphyrin (1) and 5,10,15,20-tetrakis(4-
bromomethylphenyl)porphyrin (5) 
Pyrrole (0.18 mL, 2.5 mmol) and aldehyde 4 (500.0 mg, 2.5 mmol) were added to 
CH2Cl2 (250.0 mL) under nitrogen atmosphere protected from light. The reaction started 
with the addition of methanesulfonic acid (MSA) (0.12 mL, 1.87 mmol). The reaction 
mixture was stirred for 30 min at room temperature. After this period, it was added DDQ 
(500.0 mg, 2.2 mmol) to the reaction mixture and it was maintained under stirred for more 
30 min at room temperature. The reaction was monitored by TLC and UV-Vis.  Then, the 
reaction was stopped by quenching it with water saturated with Na2CO3. The organic 
layer was separated, dried under Na2SO4 anhydrous and the solvent was evaporated under 
reduced pressure. The crude mixture was purified by column chromatography (silica gel), 
using CH2Cl2/MeOH (95:5) as eluent. The reddish less polar fraction isolated was 
identified as the porphyrin 5 (141.00 mg, 23%) and the more polar fraction with a green 
colour, corresponded to compound 1 (56.3 mg, 9%).  
 
 
5,10,15,20-tetrakis(4-bromomethylphenyl)porphyrin (5). Aspect: purple solid. Yield: 
23% (98.95 mg). 1H NMR (300 MHz, CDCl3): 
δ -2.82 (s, 2H, N-H); 4.86 (s, 8H, -CH2); 7.80 
(d, 8H, J = 8.1 Hz, H-2’,6’); 8.19 (d, 8H, J = 
8.1 Hz, H-3’,5’); 8.84 (s, 8H, β-H) ppm. MS 
(ESI (+)): m/z 987.1 [M+H]+. UV-Vis λmax nm 
(log ε) in DMF: 419 (5.87), 516 (4.42), 551 
(4.15), 592 (3.90), 647 (3.85). Fluorescence 
λmax nm in DMF: 652, 717; Quantum Yield 
(ΦFlu): ΦFlu = 0.11. 
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5,10,15,20-tetrakis(4-bromomethylphenyl)-2-aza-21-carbaporphyrin (1).  Aspect: 
dark green solid. Yield: 9% (38.6 mg). 1H NMR 
(300 MHz, CDCl3): δ (ppm) -5.0 (s, 1H, inner-
CH); 4.82 (s, 4H, -CH2); 4.84 (s, 4H, -CH2); 7.80 
(d, J = 9.2 Hz, 4H, Hm-ph); 7.87-7.91 (m, 4H, Hm-
ph); 8.11-8.15 (m, 4H, Ho-ph); 8.22-8.36 (m, 4H, 
Ho-ph); 8.50-8.65 (m, 4H, β-H); 8.71 (s,1H, H-3); 
8.95 (d, J = 4.7 Hz, 1H, β-H); 9.0 (d, J = 5.1 Hz, 
1H, β-H).MS ((ESI(+)) : m/z 987.1 [M+H]+.UV-
Vis λmax nm (log ε) in DMF: 445 (4.96), 548 
(3.91), 595 (3.95); 646 (3.96); 705 (3.98). Fluorescence λmax nm; in DMF: 650, 716 
Quantum Yield (ΦFlu): ΦFlu = 0.03. 
 
 
2.3.4 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl) 
porphyrin tetraiodide (6) 
Sodium iodide (NaI) (6.55 equiv., 20.0 mg, 0.133 mmol) was added to a mixture 
of porphyrin 5 (20.0 mg, 0.0203 mmol) in pyridine (3.0 mL). The reaction mixture was 
stirred for 5 min at room temperature. Then it was filtered with hexane and washed with 
diethyl ether and a purple solid of 6 (27 mg, 90%) was obtained. 
 
 
5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)porphyrin tetraiodide (6). 
Aspect: purple solid. Yield: 90% (27 mg). 1H 
NMR  (300 MHz, DMSO-d6): δ (ppm) -3.0 (s, 1H, 
inner C-H), 6.25 (s, 8H, -CH2), 7.97 (d, J = 8.1Hz, 
8H, H-2’,6’), 8.29 (d, J = 8.1 Hz, 8H, H-3’,5’), 
8.37 (dd, J = 6.7 Hz and J = 7.8 Hz, 8H, H-3’’’, 
5’’’), 8.76-8.80 (m, 12H, H4’’’, β-H), 9.51 (d, J = 
5.6 Hz, 8H, H- 2’’’,6’’’). 13C NMR (126 MHz, 
DMSO-d6): δ (ppm) 63.22 (-CH2), 119.38 (C-5), 
127.45 (C-3’, 5’), 128.46 (C-3’’’, 5’’’), 134.08 (C-
4’), 134.95 (C-2’, 6’), 141.99 (C-1’), 145.27 (C-2’’’, 6’’’), 146.30 (C-4’’’, C-β). MS 
((ESI(+)) : m/z 245.9 [M]4+; 225.6 [M-Py-H]4+. UV-Vis λmax nm (log ε) in DMF: 419 
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(5.63), 515 (4.49), 551 (4.16); 590 (3.96); 647 (3.87). Fluorescence λmax nm in DMF: 
651, 716; Quantum Yield (ΦFlu): ΦFlu = 0.10. 
 
 
2.3.5 Synthesis of 5,10,15,20-tetrakis(4-(pyridinium-1-yl-
methyl)phenyl)-2-aza-21-carbaporphyrin tetraiodide (2)  
NaI (6.0 equiv. 20 mg, 0.133 mmol) was added to a stirred solution of porphyrin 
1 (20 mg, 0.0203 mmol) in pyridine (3 mL). After 30 min at room temperature the reaction 
was ended. This was confirmed by TLC and the reaction mixture was filtered with hexane 
and wash with diethyl ether. Then a green dark solid was obtained (24.8 mg, 82%). 
 
 
5,10,15,20-tetrakis(4-(pyridinium-1-yl-methyl)phenyl)-2-aza-21-carbaporphyrin 
tetraiodide (2). Aspect: green dark solid. Yield: 
82% (24.8 mg). 1H NMR (300MHz, DMSO-d6 at 
50ºC) : δ (ppm) 6.12-6.23 (m, 8H, -CH2); 7.80-8.03 
(m, 16H, H-Ph); 8.11-8.15 (m, 2H, β-H, H-Py); 
8.30-8.36 (m, 8H, H-Py); 8.67 (s, 1H, H-3); 8.74( t, 
J = 7.6, 4H, H-Py); 9.24 (s, 4H, β-H); 9.40-9.49 (m, 
8H, H-Py). MS ((ESI (+)): m/z 274.5 [M-2Py-H]3+; 
m/z 225.8 [M-Py-H]4+. UV-Vis λmax nm (log ε) in 
DMF: 453 (4.92), 549 (3.79), 598 (7.89); 643 (3.90); 690 (3.93). Fluorescence λmax nm 
in DMF: 650, 714; Quantum Yield (ΦFlu) : ΦFlu = 0.04. 
 
 
2.3.6 Irradiation conditions for 1O2 generation 
A LED array composed by a matrix of 5x5 LED making a total of 25 light sources 
with an emission peak centred at 640 nm ± 20 nm was used. The irradiance of the LED 
was 9 mW.cm-2 (measured with a light meter LI-COR model LI-250, LI-COR inc., USA) 
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2.3.7 Singlet oxygen generation 
The singlet oxygen production was qualitatively evaluated through absorbance 
decay of DPiBF, a singlet oxygen quencher. Stock solution of each porphyrin at 0.1 mM 
in DMF was prepared.  
A solution of 50 µM of DPiBF and 0.5 µM of a porphyrin in DMF in glass cuvette 
(3 mL) at room temperature and under gentle magnetic stirring was irradiated with a LED 
array at 640 nm ± 20 nm (red light) with an irradiance of 9 mW.cm-2. The absorbance 
decay of DPiBF at 415 nm was measured 1 min irradiation intervals up to 10 min. The 
solution of DPiBF (50 µM) without PS was used to evaluate the DPiBF 
photodecomposition under the irradiation conditions. The graphic reporting Ln (A/A0) 
for 10 min of irradiation was done, being A  the absorbance of the DPiBF at 415 nm and 
A0 the absorbance at 0 min. 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3 
Can photodynamic therapy interfere with 
alternative splicing of mRNA ? 
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3.1 General remarks 
Before doing any assays with the synthesized porphyrins to verify if their ability 
to induce mRNA alternative splicing in MCF-7 cells under PDT conditions, it is important 
to establish the experimental conditions (concentration and light dose) to reach 50% of 
mortality. This is the ideal mortality for the RNA splicing assays in this breast cancer cell 
line. For that reason, three different methods (WST-1, ATPliteTM and Trypan Blue) to 
check the MCF-7 cells viability were effectuated. The subcellular localization and cellular 
uptake was also investigated.  
After checking the cell viability, it is also important to know which type of cell 
death the studied compounds induce after PDT treatment. As it was discussed in chapter 
1, there are four main types of cell death: apoptosis, necrosis, necroptosis and autophagy. 
Cell death type was determined by Western blotting. Protein extracts from MCF-7 cells 
after the photodynamic treatment were analysed with different antibodies according to 
the type of cell death under evaluation. 
Finally, the possibility of alternative splicing was assessed in MCF-7 cells by 
extracting the total RNA from cells previous submitted to photodynamic treatment. A 
reverse transcriptase polymerase chain reaction (RT-PCR) was performed in the total 
RNA with specific primers. The PCR products were separated by electrophoresis. 
All the results presented in this chapter were obtained in GIGA-Institute of 
University of Liège with the collaboration of Drs Jacques Piette and Yvette Habraken. 
 
3.2 Viability assays  
3.2.1 Measurement of cell viability using the Cell Proliferation 
Reagent WST-1  
WST-1 (Water soluble Tetrazolium, sodium (4-[3-(4-Iodophenyl)-2(4-
nitrophenyl)-2H-5-tetrazolium)-1,3-benzene disulphate) reagent was selected for 
spectrophotometric quantification of cell proliferation growth, viability, and 
chemosensitivity in cell populations using a 96 well-plate. This reagent was chosen 
because it can be used to analyse the cytotoxicity of certain compounds such as anti-
cancer drugs or other pharmaceutical compounds.109 
The principle of this assay is based on the reduction of tetrazolium salt into 
formazan by cellular enzymes (Scheme 12).110 So, if the cells are dead there is a decrease 
in the overall activity of mitochondrial dehydrogenases in the sample.110 The 
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diminishment of enzyme activity leads to a decrease in the amount of formazan dye 
formed, which is directly correlated with the number of deceased (metabolically inactive) 
cells in culture. The quantification of the formazan dye produced by metabolically active 
cells is done by a spectrophotometer where the absorbance at 450 nm is measured against 
the background control at 690 nm.109 
 
Scheme 12. Cleavage of the tetrazolium salt WST-1 by its reduction to formazan. The enzyme involved is the 
mitochondrial succinate-tetrazolium-reductase system. ECR: Electron coupling reagent. 
 
 
3.2.1.1 Cell viability assay with WST-1 in HeLa Cells 
In the first assays HeLa cells were used. First, after plating the cells in 96-well 
plates each compounds 1, 2, 5, 6 and TMPyP was added at a concentration of 5.0 µM. 
TMPyP was used as a positive control for the synthesized compounds because it is known 
that it is a good PS in PDT.99 Camptothecin (CPT) was also added as a positive control 
at a concentration of 20 µM. Light and dark controls were also included. The cells were 
incubated with each compound for 3 h and then irradiated with red light for 15 min with 
a wavelength >640 nm and an irradiance of 23.70 mW/cm2. After 24 h of dark incubation, 
10.0 µL of WST-1 was added for 30 min to each well. Then, the absorbance at 450 nm 
was measured as well as at 690 nm for the background. The “corrected” absorbance was 
calculated by subtracting the absorbance at 450 nm from the absorbance at 690 nm. The 
cell survival was calculated by doing the relationship between the treated and the control 
cells both in presence of light. The results are summarized in Figure 27 and Table 4 
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Figure 27. Survival rates of HeLa cells incubated with 5.0 µM of each PS and 20 µM of CPT for 3 h, then 
irradiated for 15 min (contoured bars) with red light (λ > 640 nm) at an irradiance of 23.70 mW/cm2 or kept in 
the dark (full coloured bars). 
 
Table 4. Percent survival of HeLa cells incubated with 5.0 µM of each PS and 20 µM of CPT for 3 h, then 
irradiated for 15 min with red light (λ >640 nm) at an irradiance of 23.70 mW/cm2 or kept in the dark. 
Compound Cell Survival in 
the dark (%) 
Cell survival 
after PDT (%) 
1 (5.0 µM) 94.9 116.3 
2 (5.0 µM) 99.9 101.9 
5 (5.0 µM) 82.0 115.0 
6 (5.0 µM) 100.0 16.2 
TMPyP (5.0 µM) 108.5 33.7 
CPT (20 µM) _______ 32.8 
 
 The results obtained in Figure 27 and Table 4 show that the phototoxic effect is 
more pronounced with compound 6 (16.2%), being even higher than the positive controls 
CPT (32.8%) and TMPyP (33.7%) used. 
 
 
3.2.1.2 Cell Viability assay with WST-1 in MCF-7 Cells 
 After the preliminary results, MCF-7 cells (human breast adenocarcinoma cell 
line) were selected to perform the experiments as they exhibit strong AS with numerous 
chemotherapeutic drugs. Different concentrations of derivatives 1, 2, 5 and 6 (1.0 and 5.0 
µM) were administrated to cell cultures and the cells were submitted to the photodynamic 
treatment. A light and dark controls were also included. After 24 h the WST-1 reagent 
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was added and the absorbance was measured after 1 h. The survival rates obtained 
(Figure 28 and Table 5) show that no significant dark cytotoxicity was observed at 
concentrations up to 5.0 µM. (Figure 28-B) 
 
 
Figure 28. Survival rates of MCF-7 cells incubated with 1.0 µM and 5.0 µM of each PS for 3 h, then irradiated 
for 15 min (A) with red light (λ > 640 nm) at an irradiance of 23.70 mW/cm2 or kept in the dark (B) 
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Table 5. Percent survival of MCF-7 cells incubated with 1.0 µM and 5.0 µM of each PS for 3 h, then 
irradiated for 15 min with red light (λ > 640 nm) at an irradiance of 23.70 mW/cm2 or kept in the dark. 
Compound 
1.0 µM  5.0 µM  
Dark Light Dark  Light 
1 70.40 71.32 ± 4.39 93.07 79.83 ± 0.92 
2 80.36 77.97 ± 3.80 102.19 86.72 ± 2.68 
5 80.16 76.58 ± 2.38 91.40 74.99 ± 3.80 
6 73.40 51.20 ± 17.85 87.16 24.34 ± 2.06 
TMPyP 91.11 75.88 ± 6.37 108.42 35.8 
CPT 
20 µM 
Dark Light 
69.01 ± 0.98 79.83 
 
Regarding the irradiated cells, it is possible to observe that only compound 6 and 
TMPyP can kill more than 50% of the cells after 15 min of irradiation and at a 
concentration of 5.0 µM. However, porphyrin 6 at a concentration of 1.0 µM was able to 
kill almost 50% of cells (cells survival 51.20 %). It is important to highlight that the cell 
photokilling is not cell line dependent.  
After this assay, only compound 6 and TMPyP were selected to proceed with the 
photodynamic therapy assays in order to assess if the cell killing is dose-dependent and/or 
light-dependent. So the cell cultures were incubated for a period of 3 h in the presence of 
non-cytotoxic concentrations of each porphyrin (0.1 µM-5.0 µM ) and then submitted to 
different times of irradiation (5, 10 and 15 min) with a wavelength >640 nm and an 
irradiance of 23.70 W/m2. After 24 h, WST-1 reagent was added and the absorbance 
measured after 1 h. The results obtained for the cell survival (see Table 6 and Figure 29)  
show that the synthesized derivative 6 seems to be a better PS than the well-known 
TMPyP selected as positive control.  
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Table 6. Percent survival of MCF-7 cells incubated with 0.1, 0.25, 0.5, 1.25, 2.5 and 5.0 µM of porphyrin 
6 and TMPyP for a period of 3 h, then irradiated for 15 min with red light (λ > 640 nm) at an irradiance of 23.70 
mW/cm2 or kept in the dark. 
Porphyrin 6 
Concentration 
(µM) 
Dark control  
Irradiation time (min) 
5 10 15 
0.10  110.6 ± 6.2 105.3 ± 5.6 109.1 ± 10.5 
0.25 110.0 ± 4.6 93.2 ± 21.4 99.0 ± 17.3 
0.50 105.8 ± 5.6 108.8 ± 5.1 67.2 ± 13.7 
1.25 97.1 ± 6.6 70.6 ± 11.4 27.5 ± 6.15 
2.50 103.5 ± 10.7 87.0 ± 7.5 33.5 ± 10.7 22.5 ± 3.9 
5.0 104.3 ± 10.7 55.9 ± 19.7 28.0± 4.3 26.3 ± 7.8 
Porphyrin TMPyP 
Concentration 
(µM) 
Dark control  
Irradiation time (min) 
5 10 15 
0.10  11.23 ± 7.68 106.97 ± 9.82 116.95 ± 18.17 
0.25 117.17 ± 5.71 117.9 ±4.16 119.95 ± 23.83 
0.50 116.63 ± 10.06 109.73 ± 11.21 117.85 ± 23.26 
1.25 114.70 ± 11.88 109.77 ± 10.35 85.35 ± 9.97 
2.50 127.57 ± 17.25 119.73 ± 14.66 114.73 ± 9.87 51.00 ± 12.73 
5 141.47 ± 17.68 125.70 ± 20.30 97.60 ± 20.88 39.15 ± 5.87 
 
 
 
0
20
40
60
80
100
120
0 1 2 3 4 5
C
el
l 
su
rv
iv
a
l 
(%
)
Concentration of 6 (µM)
50 % mortality Dark control 5 min 10 min 15 min
A 
  Chapter 3 
University of Aveiro  63 
 
Figure 29. Survival rates of MCF-7 cells incubated with 0.10, 0.25, 0.50, 1.25, 2.5 and 5.0 µM of porphyrin 6 (A) 
and TMPyP (B) for 3 h, then, irradiated for 15 min with red light (λ >640 nm) at an irradiance of 23.70 mW/cm2 
or kept in the dark. 
 
These results show that the cell photokilling is dependent in both cases of PS 
concentration and irradiation time (Figure 29 and Table 6). 
 Regarding porphyrin 6, for concentration of 1.25 µM there is a difference 
between the mortality using 10 or 15 min of irradiation with a significance level of 0.07. 
(95% of confidence). On the other hand, for concentrations of 2.5 µM the difference 
between the mortality by using 10 or 15 min of irradiation is not statistically significant 
(p = 0.24). It is important to highlight that a high photocytotoxicity (survival fractions of 
about 20%) can be observed when using porphyrin 6 at concentration 2.5 µM and after 
15 min of irradiation. However, there is no significant difference between concentrations 
2.5 and 5.0 µM at 10 and 15 min of irradiation because the mortality is already too high 
(p = 0.53). 
As it can be seen in Figure 29 and Table 6, TMPyP only can induce 
approximately 50% mortality with 15 min of irradiation and only with a concentration of 
2.5 µM. The maximum mortality (39.15% of cell survival) is achieved with 15 min of 
irradiation at a wavelength of 640 nm and an irradiance of 23.70 mW/cm2 and at a PS 
concentration of 5.0 µM.  
However, it was proved that due to their colour both porphyrin 6 and TMPyP 
could interfere with the absorbance of WST-1 reagent. It is to be noted that the 
interference of the TMPyP is more pronounced. For this reason, another cell viability test 
called ATPliteTM assay was used to see if the results with this new test are concordant 
with the ones obtained with WST-1 reagent.  
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3.2.2 Cell viability assay using ATPliteTM kit 
ATP (adenosine triphosphate) is a molecule responsible for energy storage in 
every living cell. For this reason, its monitorization can be an alternative for the usual cell 
survival assays. That is the case of the ATPliteTM kit which is an ATP monitoring system 
based on firefly (Photinus pyralis) luciferase (Figure 30). This luminescence assay can 
be used as an alternative to colorimetric and quantitative evaluation of proliferation due 
to its advantages regarding high sensitivity and excellent linearity.111,112 
This method is based on production of light induced by the reaction of ATP 
luciferase and D-Luciferin (the last two added). 
 
 
Figure 30. ATPliteTM method basis 
It is known that the concentration of ATP declines when cells die. So, the 
concentration of ATP can be estimated because it is proportional to the light emitted and 
by measuring the light emitted it is possible to calculate the percentage of cell death.  
 
 
4.2.2.1 Dose dependence assay 
Porphyrin 6 and TMPyP were added to MCF-7 cell cultures and then incubated 
for 3 h in the dark. Concentrations of 1.25 µM, 2.5 µM and 5.0 µM were selected for 
porphyrin 6 and 5µM and 10 µM for TMPyP. This concentrations selection was based 
on the percentages of survival detected by WST-1. That range of concentration should 
give more or less 50% survival. All the cells were incubated with the studied PS at the 
Photinus Pyralis (firefly) 
Luciferase ATP+ D-Luciferin + O
2
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2
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selected concentrations but a group of cells was irradiated for 15 min with a wavelength 
of >640 nm and an irradiance of 23.70 mW/cm2 and another group was kept in dark. After 
24 h the ATPliteTM cell viability test was done and the results are shown in Figure 31 and 
Table 7. 
 
Table 7. Percent survival of MCF-7 cells using ATPliteTM incubated with 1.25, 2.5 and 5.0 µM of 
porphyrin 6 and 5 µM and 10 µM TMPyP in the dark for a period of 3 h and kept in the dark or irradiated for 
15 min with red light (λ >640 nm) at an irradiance of 23.70 mW/cm2. The cell survival was analysed after 24 h. 
Compound Concentration 
(µM) 
Irradiation time 
(min) 
Dark controls Cell Survival 
(%) 
6 
1.25 
15 
 
88.14 ± 3.83 82.81 ± 12.46 
2.5 87.43 ± 4.19 68.81 ± 17.20 
5.0 96.66 ± 19.92 38.80 ± 11.49 
TMPyP 
5.0 100.69 ± 16.63 77.52 ± 7.24 
10 91.25 ± 18.28 76.28 ± 32.20 
  
Porphyrin 6 shown higher phototoxic activity than TMPyP at the same 
concentration (5.0 µM) after 15 min of irradiation reaching a cell survival of 38.80% and 
77.52%, respectively. Even at 10 µM, TMPyP was not able to reach 50% of mortality. 
Although, these results were different from the WST-1 assay the main conclusion is that 
porphyrin 6 has a higher photokilling effect on MCF-7 cells than TMPyP. 
 
Figure 31. Survival rates of MCF-7 cells using ATPliteTM incubated with 5.0 µM of porphyrin 6 and 10 
µM of TMPyP in the dark for a period of 3 h and kept in the dark or irradiated for 15 min with red light (λ >640 
nm) at an irradiance of 23.70 mW/cm2. 
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4.2.2.2 Time post-PDT dependence assay 
A time-dependence assay was conducted to see if the photocytotoxicity effect 
increases with time after irradiation. So, after a 3h incubation with compounds 6 and 
TMPyP at concentrations of 5.0 µM and 10 µM, respectively, MCF-7 cells were 
irradiated for 15 min with a wavelength >640 nm and an irradiance of 23.70 mW/cm2. 
Then, the ATPlite™ assay was performed at 0, 3, 6 and 19 h after irradiation. The 
concentrations used were selected according to the dose-dependence assay results. The 
results obtained are shown in Figure 32 and Table 8 . 
 
Table 8. Percent survival of MCF-7 using ATPliteTM cells incubated with 5.0 µM of porphyrin 6 and 
10 µM of TMPyP in the dark for a period of 3 h and kept in the dark or irradiated for 15 min with red light (λ 
>640 nm) at an irradiance of 23.70 mW/cm2. Different times of incubation after PDT were used to calculate the 
cell survival percentages. 
6 (5.0 µM)  TMPyP (10 µM) 
Dark controls Cell Survival 
(%) 
Time after 
irradiation 
(h) 
Dark controls Cell Survival 
(%) 
74.33 105.32 ± 12.94 0 75.15 73.00 ± 8.45 
86.80 77.78 ± 31.06 3 98.25 71.54 ± 23.55 
63.22 73.19 ± 18.85 6 74.87 82.29 ± 18.73 
108.25 27.20 ± 13.63 19 137.36 78.09 ± 18.55 
96.66 ± 19.92 38.80 ± 11.49 24 91.25 ± 18.28 76.28 ± 32.20 
  
 The results show that after 3 h after irradiation, both compounds do not induce 
significant cell death. However, 19 h post-irradiation a significant photocytotoxicity 
effect appears for porphyrin 6, being the cell survival percentage of 27.20%. Regarding 
TMPyP, 19 h or 24 h are not sufficient for reaching 50% of cell mortality.  
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Figure 32. Survival rates of MCF-7 cells using ATPliteTM incubated with 5.0 µM of porphyrin 6 and 10 µM of 
TMPyP in the dark for a period of 3 h and kept in the dark or irradiated for 15 min with red light (λ >640 nm) 
at an irradiance of 23.70 mW/cm2. Different times of incubation after PDT were used to calculate the cell survival 
percentages.  
 
Regarding time-dependence assay, it is better to leave the cells for 24 h (more than 
the 19 h used) in the incubator before doing the assay in order to get a low cell survival 
percentage for porphyrin TMPyP. Despite of having already a low cell survival 
percentage within 19 h samples (27.20 ±11.49 %), porphyrin 6 should be in the incubator 
for the same time as TMPyP in order to be able to compare each other’s cell mortality. 
 Concerning the dose dependence assay, the difference between the two methods 
is statically significant (p = 0.013) and for that reason is not possible to compare both 
methods or even to know which one is better. The only conclusion that is possible to take 
is that 6 is a better PS than TMPyP.  
 
 
3.2.3 Cell viability assay using Trypan Blue 
A third assay named trypan blue exclusion was also used, in order to confirm the 
cell viability results obtained by ATPliteTM and WST-1 assays. This type of assay is 
currently used in PDT field, so it was considered important to validate the previous 
results. 
Trypan blue is a dye used for dye exclusion procedures for viable cell counting. 
The method is based on a simple principle: live/viable cells actively excluded certain dyes 
while death/non-viable cells do not.113 
0
20
40
60
80
100
120
140
160
0 3 6 9 12 15 18
C
el
l 
S
u
rv
iv
a
l 
(%
)
Time (hours)
50% mortality 6 Dark control 6 Dark control TMPyP TMPyP
Chapter 3 
68   University of Aveiro 
Different concentration of porphyrin 6 (0.75; 1.25; 2.5 and 5.0 µM) and TMPyP 
(2.5; 5 and 10 µM) were administrated to MCF-7 cell cultures which was followed by a 
incubation period in the dark for 3 h. Then, one set of cells was irradiated for 15 min with 
red light with a wavelength of 640 nm and an irradiance of 23.70 mW/cm2 and the other 
was kept in the dark. After irradiation, the cells were placed in the incubator for 24 h. 
Then the trypan blue was added and pictures of the cells were taken after washing. The 
results are represented in Figure 33 and Figure 34. 
 
 
Figure 33. Cell mortality using trypan blue in MCF-7 cells after 3 h incubation with porphyrin 6, then irradiated 
for 15 min with a wavelength >640 nm and an irradiance of 23.70 mW/cm2 or kept in the dark. The 
concentrations used are 0 µM (A); 0.75 µM (B); 1.25 µM  (C); 2.5 µM  (D); 5.0 µM (E) and dark control 5 (F) 
E F 
C D 
A B  
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 In Figure 33 are shown the results obtained with porphyrin 6, and it is clear that 
there is an increase in the mortality when the concentration was increased from 0 µM (A) 
to 5.0 µM (E); at the highest concentration, almost every cell is dead (E). Nor light nor 
the PS 6 at the highest concentration (5.0 µM) without irradiation affect the mortality of 
MCF-7 cells. These results are consistent with ATPliteTM and WST-1 assays where with 
5.0 µM and 15 min irradiation it was observed 38.8% and 24.34% of cell survival, 
respectively.  
Figure 34. Cell mortality using trypan blue in MCF-7 cells after 3 h incubation with porphyrin TMPyP, then 
irradiated for 15 min with a wavelength >640 nm and an irradiance of 23.70 mW/cm2 or kept in the dark. The 
concentrations used are 0 µM (A); 2.5 µM  (B); 5.0 µM (C); 10 µM (D) and dark control 10 µM (E). 
E 
A B 
C D 
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Regarding TMPyP ( Figure 34) similar results were observed although the cell death 
was not so extensive as with porphyrin 6 (Figure 33). These results can illustrate the 
percentages obtained with ATPliteTM assays where with 15 min of irradiation and at 5 
µM it was observed 77.52% of cell survival. However, with the same conditions and using 
WST-1 assay the percentage obtained for cell survival was 39.15% which is not in 
agreement with the results represented in Figure 34-C picture. 
 
 
3.3 Cellular uptake 
The cellular uptake in MCF-7 cells was monitored through intracellular 
fluorescence using only the fluorescent regular porphyrins 5, 6 and TMPyP. In these 
experiments the fluorescence spectrum was taken and compared with the one of the 
correspondent porphyrin. The cells were incubated with each porphyrin for 4 h at 10 µM. 
Then, they were washed with PBS for 1 min and DMSO was added for 10 min under 
gentle stirring. Finally, the fluorescence was read at different wavelengths according to 
each porphyrin’s absorption spectrum. A negative (MCF-7 cells by itself) control and a 
fluorescence spectrum of the compound after washing were made and the results are 
presented in Figure 35. 
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Figure 35. Fluorescence spectra of porphyrins 5 (C- λexc= 425 nm), 6 (D- λexc= 425 nm) and TMPyP (E- λexc= 425 
nm) in DMSO/DMEM. Negative control represents MCF-7 cells by itself and the positive control just porphyrin. 
 
In Figure 35 is clear that the highest uptake by MCF-7 cells was attained with 
porphyrin 6 (B), followed by porphyrin 5 (A) despite its neutral character. There was a 
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very limited uptake of TMPyP (C) by MCF-7 cells. This can be seen when comparing 
the spectrum of TMPyP with the TMPyP that stuck to the plastic.  
 
 
3.4 Subcellular localization 
The efficiency of a photosensitizer depends on its subcellular localization. 
Moreover, the lifetime and diffusion length of 1O2 are very short (0.5 and 0.1 µs 
respectively).114 Thus, the initial oxidative reaction will occur in subcellular organelles in 
which the PS are located.115 The subcellular localization of porphyrins 5, 6 and TMPyP 
in MCF-7 cells was determined by considering the red fluorescence emission (λ= 607-
708 nm) after being excited with violet radiation (λ=448 nm). The subcellular localization 
of porphyrins 1 and 2 was not determined since they are not fluorescent. 
The previous results confirmed that porphyrins 5, 6 and TMPyP enter in the cells. 
From literature it is known that TMPyP accumulates in the nucleus,.116 So, in this assay 
the cells were stained with Hoescht, a fluorescent marker for the nucleus in order to verify 
this  possibility. 
So, MCF-7 cells were incubated for 3 h with all porphyrins, using a concentration 
of 10 µM for TMPyP and 5.0 µM for porphyrins 5 and 6. The results are shown in Figure 
36. 
In the cell controls no PS was added, but the fluorescence was measured in the 
same conditions in order to see if the cell or the medium fluorescence interferes with the 
compound.  
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Figure 36. Intracellular localization of porphyrin 5 (D-F), 6 (G-J) and TMPyP (J-L) in MCF-7 cells 
after incubation with each derivative for 3 h at 5.0 µM in Dulbecco’s Modified Eagle’s Medium (DMEM). A, D 
and G concerns the fluorescence of porphyrins, B, E, I the Hoechst fluorescence and C, F, J the overlay images. 
Controls were also made (A-C). 
 
It is described in literature that the sub-localization of the PS is dependent mainly 
of its charge. For example, cationic porphyrins have high affinity to the nucleus, 
particularly TMPyP which can induce apoptosis after PDT due to DNA damage.116 
Porphyrin TMPyP was clearly localized in the nucleus, as seen in (Figure 36 J-
L). A different situation was observed with the neutral porphyrin 5 (Figure 36 D-F) and 
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also with the charged porphyrin 6 (Figure 36 G-J) where no porphyrin localization was 
detected in the nucleus 
These results show that porphyrin 6, despite of being cationic and inducing the 
highest mortality after PDT, does not accumulate in the nucleus. However, the 
accumulation in other organelles can be considered as it is described in the literature for 
other cationic porphyrins.116  
 
 
3.5 Type of cell death induced by photodynamic therapy with porphyrin 
6 and TMPyP 
3.5.1 General background 
There are three main types of cell death: apoptosis, autophagy and 
necrosis/necroptosis. So, it was decided to study and assess the type of cell death induced 
by PDT with porphyrin 6 and TMPyP. 
As it was said before, DNA damage can induce programmed cell death like 
apoptosis. There are several markers for this type of cellular death such as caspase-3, -7 
or PARP-1. The antibodies for these proteins can be used in a western blot in order to 
detect if the apoptosis process is present. Given that MCF-7 cells do not have caspase-3, 
PARP-1 cleavage was followed as an apoptosis marker. This is the most common marker 
used for study this type of cell death and has good results regarding camptothecin (CPT) 
that was also used as a positive control for this study. It is known that during apoptosis 
process the cleavage of full length PARP-1 (116 kDa) is generated by caspase-3 and 7 
into two fragments of 89 kDa and 24 kDa (Figure 37).117 
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Figure 37. PARP-1 (116 kDa) cleavage between Asp214 and Gly215 by caspase-3 or -7 in apoptosis into 
two fragments with 24 kDa and 89 kDa.118 
 
There are several ways to monitor if the cells undergo necrosis including a 
cleavage of PARP-1. However, in this case there are two main enzymes responsible for 
this cleavage: cathepsins and papains. If the first type of enzymes cleaves PARP-1, it can 
origin the formation of the fragments with 42 kDa and 55 kDa or 62 kDa and 55 kDa. On 
the other hand, the fragments derived from PARP-1 cleavage with papains have 42 kDa 
and 72 kDa or 42 kDa and 55 kDa (Figure 38).118 So, in order to have a single membrane 
with the results for the apoptotic and necrotic pathway, a primary PARP antibody that 
can recognize both the necrotic and apoptotic fragments was used.  
 
 
Figure 38. PARP-1 (116 kDa) cleavage by cathepsins in necroptosis into two fragments with 42 kDa 
and 55 kDa.118 
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Autophagy is essential for cell maintenance and cell viability. There are many 
proteins involved in the formation of the autophagossome including LC3-II. This protein 
can be used as a marker for autophagy due its location in the autophagossome. LC3-II is 
originated from the modification of LC3-I. So when the autophagic flux is activated, it is 
expected to appear in the western membrane a band representing LC3-II while there is a 
disappearance of LC3-I (Figure 39).119,120  
 
Figure 39. Formation of the autophagossome in the presence of LC3-II (14 kDa) which derived from LC3-I (16 
kDa).120  
When the necrosis process occurs, there is a permeabilization of the cytoplasmic 
membrane in the early process. This causes the release of several proteins to outside the 
cell such as cyclophilin A, as it can be seen in Figure 40.121 
 
Figure 40. Permeabilization of the cytoplasmic membrane and release of several organelles and 
proteins including Cyclophilin A.121 
 
 
 
3.5.2 General procedure to access type of cell death 
MCF-7 cells were incubated with porphyrin 6 (2.5 µM and 5.0 µM) and TMPyP 
(5.0 µM and 10 µM) for 3 h. Then, the cells were irradiated for 15 min with red light at 
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an irradiance of 23.70 mW/cm2. Cells irradiated or not were incubated at 3, 6 and 20 h 
post-irradiation and lysed to prepare protein crude extracts. The presence of cell type 
specific proteins or fragments of protein was assessed by wester blotting. Different 
positive controls and primary antibodies were used depending on which cell type of death 
we intended to study. In order to have the same amount of protein in each well of the 
polyacrylamide gel, a protein dosage was effectuated. The amount of protein deposited 
in each well is referred in every western membrane image’s subtitle and which primary 
antibody was used is referred in the introductory text of the next subsections. HSP60 was 
used as a loading control for PARP and LC3. 
 
 
3.5.3 Apoptosis and necroptosis pathway - the cleavage of PARP-1 
The positive control used to study if the cells undergo apoptotic deathy was CPT 
20 µM for 18 h. The western membrane was incubated with an antibody that recognizes 
the 42 kDa, 62 kDa, 116 kDa (full length) and 89 kDa PARP fragments. The results are 
represented in Figure 41. 
 
 
Figure 41. Western blot analysis to detect PARP-1 cleavage in MCF-7 cells treated 3 h with PS 6 (A) 
and TMPyP (B) with different concentrations 2.5 µM; 5 µM and 5.0 µM; 10 µM, respectively. After, they were 
irradiated for 15 min and all proteins were extracted after 0, 3, 6 and 20 h post irradiation or mock treatment.  
5.7 µg (A) or 20 µg (B) of each sample were deposited in the well and the PVDF membrane probed with anti-
PARP antibody. HSP60 was used as a loading control. 
 
B 
A 
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As it can be seen in Figure 41-A, after PDT treatment with porphyrin 6 at 2.5 µM 
and 5.0 µM, there is a disappearance of full length PARP-1 (116 kDa) without the 
appearance of smaller fragments (89 kDa, 62 kDa or 42 kDa). Even with longer 
incubation periods there is no appearance of the 89 kDa, 62 kDa or 42 kDa fragment. So, 
neither apoptosis or necrosis is responsible for the death of porphyrin 6-treated MCF-7 
cells. Regarding TMPyP (Figure 41-B) there is a slight cleavage of PARP-1 related to 
apoptosis at 3 h with 10 µM but there is still a loss of full length PARP without the 
presence of the smaller fragments (89 kDa, 62 kDa or 42 kDa). So, TMPyP does not 
induce the apoptosis or the necrosis pathway. 
 
 
3.5.4 Autophagy – Transformation of LC3-I into LC3-II 
The western blot was made with an anti-LC3 antibody that could recognize both 
forms (I and II). The C-terminal glycine of LC3-I is modified by addition of 
phosphatidyletanolamine (PE) to form LC3-II. CPT 20 µM was used as a positive control 
as in the previous assay. The results are shown in Figure 42 . 
 
 
Figure 42. Western blot analysis to detect the two LC3 forms (LC3-I and LC3-II) in MCF-7 cells 
treated 3 h with PS 6 (A) and TMPyP (B) with different concentrations 2.5 µM; 5 µM and 5.0 µM; 10 µM, 
respectively. After, they were irradiated for 15 min and then all proteins were extracted after 0, 3, 6 and 20 h.  
5.7 µg (A) or 20 µg (B) of protein were deposited in each well and the PVDF membrane probed with anti-PARP 
antibody. HSP60 was used as a loading control. 
 
Regarding 6, as seen in Figure 42, it is not possible to conclude if the 
concentration or time of protein extraction after irradiation influences the activation of 
the autophagy. However, there is an appearance of LC3-II with all the samples. Regarding 
A 
B 
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TMPyP there is an autophagic flux and the compound by itself seems to induce some 
autophagy. So, the cells seem to undergo autophagy after PDT with porphyrin 6 and 
TMPyP. However, the autophagic flux does not long until the 20 h samples and the 
appearance of LC3-II is visible in the dark controls. So, the appearance of LC3-II is does 
not mean that autophagy is responsible of the death after PDT.  
It was previous reported that autophagy can block the apoptotic pathway in cancer 
cells, protecting them against cancer treatment. This is called “protective autophagy”. 
These facts can be related to the results shown above when there is autophagy but the 
apoptotic process is absent (loss of PARP) (Figure 41 and Figure 42).  
 
 
3.5.5 Necroptosis- Release of Cyclophilin A 
 Methyl methanesulfonate (MMS) 25 mM was chosen as positive control. There 
is no need to harvest the cells, instead it is necessary to collect the medium (DMEM) 
because, as said before, when necroptosis occurs Cyclophilin A is released to the 
extracellular medium. However, the cells were harvested and used for PARP and LC3 
westerns, described before. The results from incubation with Cyclophilin primary 
antibody are shown in Figure 43. It was not used a loading control because HSP60 is 
localized inside the cell and cyclophilin outside it. 
 
 
Figure 43. A - Western blot analysis to detect the release of Cyclophilin A after photodynamic therapy 
with synthesized porphyrins in by MCF-7 cells. MCF-7cells were incubated with porphyrin 6 (A) and TMPyP 
(B) with different concentrations 2.5 µM; 5 µM and 5.0 µM; 10 µM, respectively, for 3 h. After they were 
irradiated for 15 min and the presence of Cyclophylin detected in 18 µL of cell supernatant 0. 3. 6 and 20 h later. 
The PVDF membranes were probed with anti-Cyclophilin A antibody 
 As it can be seen in Figure 43, there is an accumulation of Cyclophilin A caused 
by PDT with each porphyrin derivative. Moreover, porphyrin 6 shows this accumulation 
A 
B 
Chapter 3 
80   University of Aveiro 
when there is the disappearance of the full-length PARP-1. So, the cells may undergo 
necrosis. 
 It was said before, when the apoptotic machinery is damaged, another cell type of 
death can occur after PDT. So, when comparing Figure 41 and Figure 43, it is possible 
to conclude that when PARP-1 disappears there is an accumulation of Cyclophilin A 
regarding 6. This can mean that instead of undergo apoptosis, these cells suffer necrosis 
besides autophagy. Regarding TMPyP, the accumulation of Cyclophilin A is visible and 
indicates that after PDT there is also necrosis and autophagy. Both compounds show the 
accumulation of Cyclophilin A after PDT at the maximum concentration. A stable low 
level cyclophilin release is detected in the non-treated and in the treated non-irradiated 
cells that probably reflects a permanent low level necrosis in these cancerous cell line. 
 
 
3.6 Influence assessment of photodynamic therapy in alternative splicing 
of mRNA  
CoASY synthase is a bio-functional enzyme that plays and important role in 
cellular metabolism because it carries the two final stages of CoA (coenzyme A) 
biosynthesis. In vitro several isoforms of this enzyme were previously identified. The 
design of the correct primers allows to observe the respective isoform (Figure 44). In 
case of COASY gene the mRNA can be with the full-length form having 350 bp or the 
two spliced isoforms with 150 bp and 100 bp. The first one regards the skipping of exon 
4 and the second one the loss of exon 4 and 5. 122 
 
Figure 44. Primer designed and its location in the CoASY gene. Based on GenBank® 123 
 
Archaemetzincin-2 (AMZ2) is a metalloprotease and it is codified by the gene 
with the same name. Proteases are very important because they mediate several key 
processes such as, for example, cell cycle progression, apoptosis and autophagy. The 
design of the correct primer allows to recognize the mRNA for the full length form (452 
bp) and the spliced isoform without exon 3 (ΔE3) with 278 bp (Figure 45).124 
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Figure 45. Primer designed and its location in the AMZ2 gene. Based on GenBank® 123 
 
The cyclic AMP-dependent transcription factor ATF-3 is a protein coded by ATF3 
gene which has an important function such as binding to DNA to promote transcription. 
There two spliced isoforms of the full length mRNA (546 bp) identified as ATF3ΔZip2a 
(858 bp) and ATF3ΔZip2b (767 bp). It is possible to observe these isoforms, with a primer 
design for that purpose. (Figure 46).124 
 
Figure 46. Primer designed and its location in the ATF3 gene. Based on GenBank® 123 
 
p53 is a tumour suppressor due to its crucial function in preventing cancer 
formation.  This protein is codified by the gene TP53. There are several isoforms of these 
protein and some of them are highly expressed in cancer cells. Its mRNA can be identified 
by designing the correct primer as it can be shown in Figure 47. Depending on which 
primer we choose; it is possible to detect different fragments 125 as it can be seen in Figure 
47.  
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Figure 47. Different primers designed for the p53 gene and its location. Based on GenBank® 123 
 
MCF-7 were treated with the same conditions as described in section 3.5.2. 
Twenty-four hours post-irradiation the RNA was extracted according to the instructions 
given by the manufacturer of the RNA purification kit used (Roche). The RT-PCR was 
done with different primers depending on which gene was under evaluation.  
The results for CoASY are represented in Figure 48. In order to have alternative 
splicing, the two smaller isoforms must exist in higher percentage than the full length one.  
 
A 
B 
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Figure 48. Alternative splicing induced by photodynamic therapy with TMPYP, 6 and treatment with CPT. Top 
image: MCF-7 cells were checked to find alternative splicing of CoASY. The cells exposed or not to compound 
6 and TMPyp were irradiated or not.  They were analysed 24 h after treatment. RT-PCR was performed with 
specific primers for endogenous CoASY. Negative control (no compound) as well as a positive control (CPT) 
were done. The PCR products were revealed in an acrylamide gel (10%). The size of the markers is shown on 
the left side and the RT-PCR products are marked on the right side of the image. Bottom: Rates of alternative 
splicing regarding the CoASY gene. 
 
As it can be seen compound 6 and TMPYP seem to induce a small alternative 
splicing. However, this influence does not seem to be dose-dependence.  
Regarding this assay, it was possible to detect an instability in the dark controls 
that is statically significant (p = 0.37). For this reason, it is necessary to repeat and adjust 
the experimental conditions in order to improve these results.  
0% 20% 40% 60% 80% 100%
Dark control 0.0 µM
Dark control 6 2.5 µM
Dark control TMPyP 10 µM
CPT 20 µM
0.0 µM
6 0.75 µM
 6 1.25 µM
6 2.5 µM
TMPyP 5.0 µM
TMPyP 10 µM
Full length Delta exon 4 Delta exon 4-5
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The results for AMZ2 are presenting in Figure 49. As it can be seen there is the 
appearance of the 278 bp isoform but it is not higher in percentage than the 452 bp (the 
full-length form). 
 
 
 
 
Figure 49. Alternative splicing induced by photodynamic therapy with TMPYP, 6 and treatment with CPT. Top 
image: MCF-7 cells were checked to find alternative splicing of AMZ2. The cells underwent a photodynamic 
treatment with each compound and they were analysed 24 h after treatment. RT-PCR was performed with 
specific primers for endogenous AMZ2. Negative control (no compound or compound without irradiation. The 
PCR products were revealed in an acrylamide gel (10%). The size of the markers is shown on the left side and 
the RT-PCR products are marked on the right side of the image. Bottom: Rates of alternative splicing regarding 
the AMZ2 gene..  
 
0% 20% 40% 60% 80% 100%
Dark control 0.0 µM
Dark control 6 2.5 µM
Dark control TMPyP 10 µM
6 0.75 µM
6 1.25 µM
6 2.5 µM
TMPyP 5.0 µM
Full length Delta E3
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 In Figure 49 it is possible to observe that the alternative splicing does not occur 
because the spliced isoform analysed is lower than 50%. However, regarding 6, the 
spliced isoform has higher percentages with increased concentration being dose-
dependent.  
 Regarding the other genes ATF3 and p53 the gel did not show any PCR products. 
This can result from bad adjustments during the PCR conditions such as temperature 
and/or time. These conditions were adapted from other genes but considering each 
melting point. Several conditions were tried without success. Concerning p53, in addition 
to try different conditions maybe designing another primer for another p53 isoform since 
there is several of them.   
 The previous results show that CoASY seem to under AS derived from PDT but 
the same did not happened to AMZ2 gene. PDT can cause oxidative stress and by 
inducing alternative spicing, new protein isoforms can be formed. Cancer cells are 
characterized by having several protein isoforms which avoid cell death while the 
canonical form promotes it. So, if PDT seems to induce AS, maybe the isoforms formed 
can induce the cell death showed earlier in this chapter. However further tests should be 
done in order to identify which isoform of a promoting cell death protein is present in 
MCF-7 after PDT.  
 There are several studies about new alternative spliced isoforms caused by 
genotoxic agents.67,91–93 However, it is important to highlight that regarding the effect of 
PDT on alternative splicing, there is not any study exploring this theme. So, this work 
becomes relevant for its novelty and its continuation can be important to find new 
chemotherapeutic approaches.  
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3.7 Material and methods 
3.7.1 Solutions and buffers 
PBS (phosphate buffer saline): NaCl 140 mM; KCl 2.7 mM; Na2HPO4 8 mM; 
KH2PO4 1.8 mM; pH 7.4. The PBS used for cell culture was purchase from Lonza, 
Verviers, Belgium. 
Trypsin/EDTA: 0.025%, pH 7.6-7.8 purchase from Lonza, Verviers, Belgium 
PageRulerTM Prestained Protein Ladder: (2.3 to 250 kDa) (New England 
Biolabs® inc., France). 
Lysis buffer for total protein extraction (Myamato): HEPES 25 mM pH 7.50; 
NaCl 150 mM; Triton X-100 0.5%; Glycerol 10%. 
Lysis mix for total protein extraction containing protease and phosphatase 
inhibitors: 500 µL of Myamato buffer; 1 µL of 1,4-Dithiothreitol (DTT) 1 mM; 5 µL of 
PMSF (phenylmethylsulfonyl fluoride) 1 mM; 40 µL of cOmpleteTM (Roche, 
Switzerland); 6.7 µL of NaF 3.3 mM; 10µL of Na3VO4 1 mM; 5 µL of β-
glycerophosphate 25 mM; 10 µL of NPP (Nitrophenyl-phosphate) 10 mM; 442.3 µL of 
H2O. 
Loading buffer 4x (TR4x): Tris-HCl 25 mM pH 6.80; SDS 8%; Glycerol 40%; 
β-glycerolmercaptoetanol 10%; bromophenol blue  
Migration buffer used to SDS-PAGE: Tris-HCl 20 mM pH 8.00; Glycine 200 
mM; SDS 10%. 
Transfer buffer used in the western’s transference: Tris 25 mM; glycine 192 
mM; methanol 10%. 
TBST-Tween (Tris buffer Saline): Tris-HCl 20 mM pH 7.50; NaCl 15 mM, 
Tween-20 0.1% 
TBST-milk: TBST + 5% (m/v) of skimmed milk powder. 
TBE 5 x buffer (electrophoresis gel): Tris-HCl 50 mM pH 8.00; Boric acid 50 
mM; EDTA 1mM. 
Acrylamide/bisacrylamide gel (DNA electrophoresis gel) 10%: 2.0 mL 
Acrylamide/bisacrylamide 40% 29:1 (v/v); 1.5 mL of TBE 5x buffer; 3.9 mL of Water-
nuclease free; 37.5 µL of APS 10%; 7.5 µL of TEMED. 
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Polyacrylamide/bisacrylamide gel (SDS-PAGE): 
a) Stacking gel: 519 µL of acrylamide/bisacrylamide 40% 37.5:1 (v/v); 1.25 mL 
of Tris 0.5 M pH 6.80; 3.2 mL of H2O; 50 µL of SDS 10%; 50 µL of APS 
10%; 5 µL of TEMED. 
b) Gel concentration 6%: 1.87 mL of acrylamide/bisacrylamide 40% 37.5:1 
(v/v); 3.0 mL of Tris 1.5 M pH 8.8; 7.0 mL of H2O; 120 µL of SDS 10%; 90 
µL of APS 10%; 6 µL of TEMED. 
c) Gel concentration 8%: 2.49 mL of acrylamide/bisacrylamide 40% 37.5:1 
(v/v); 3.0 mL of Tris 1.5 M pH 8.8; 6.33 mL of H2O; 120 µL of SDS 10%; 90 
µL of APS 10%; 6 µL of TEMED. 
d) Gel concentration 10%: 3.11 mL of acrylamide/bisacrylamide 40% 37.5:1 
(v/v); 3.0 mL of Tris 1.5 M pH 8.8; 5.6 mL of H2O; 120 µL of SDS 10%; 90 
µL of APS 10%; 6 µL of TEMED. 
e) Gel concentration 12%: 3.68 mL of acrylamide/bisacrylamide 40% 37.5:1 
(v/v); 3.0 mL of Tris 1.5 M pH 8.8; 5.1 mL of H2O; 120 µL of SDS 10%; 90 
µL of APS 10%; 6 µL of TEMED. 
f) Gel concentration 15%: 4.67 mL of acrylamide/bisacrylamide 40% 37.5:1 
(v/v); 3.0 mL of Tris 1.5 M pH 8.8; 4.15 mL of H2O; 120 µL of SDS 10%; 90 
µL of APS 10%; 4 µL of TEMED. 
 
Nuclear lysis buffer: Tris-HCl 50 mM pH 8.00; NaCl 280 mM; NP40 0.5%; 
EGTA 2mM; EDTA 10mM; Glycerol 10%. 
“Wash buffer”: HEPES 10mM pH 7.90; KCl 20 mM; MgCl2 2mM; EDTA 0.1 
mM. 
DNA ladder sample (for 10 gels): 80µL of TBE 1x; 18 µL of glycerol blue; 2 
µL of DNA ladder of 50 bp (Invitrogen). 
Reaction mix reverse transcription: 10 ng/ml total RNA, 10 µM of dNTPs, 10x 
rTth Reverse Transcriptase Buffer, 10 mM MnCl2 solution, rTth polymerase, 20 µM 
reverse initiator primer, water nuclease-free for total volume reaction of 5 µL. 
PCR reagents: 10x PCR buffer, EGTA 7.5 mM, forward initiator primer 20 µM 
water nuclease-free for total volume reaction of 20 µM. 
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3.7.2 Statistical analysis 
All the statistical analysis was done with ANOVA analysis with Microsoft Excel 
2016. 
 
 
3.7.3 Eukaryotic cell line and cell culture 
MCF-7 (human breast adeno-carcinoma cell line) and HeLa cells (human 
epithelial cervix carcinoma) were grown in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Lonza, Verviers, Belgium), supplemented with foetal bovine serum (FBS 10%, 
Gibco, Carlsbad California, USA), non-essential amino acid (NEAA, 1%) and antibiotics 
penicillin 100 U/mL and streptomycin 100 µg/mL. DMEM supplemented with FBS, 
amino acids and antibiotics will be referred to as media. Cells were grown in a HERAcell 
incubator (Heraeus, Kendro, Germany) with 5% of CO2 atmosphere, 95% relative 
humidity and a constant temperature of 37ºC. The cells used for all the assays were plated 
24 h prior to the experimental to be at about ~80% confluence at the time of the drug 
addition. 
 
 
3.7.4 Photodynamic treatments 
MCF-7 cells were grown overnight in the respective plates until they reach ~80% 
confluence and incubated with an appropriate volume of PS. The synthesised compounds 
were diluted in DMSO at 10mM and further diluted in DMEM just prior to cell contact. 
After 3 h of incubation, the cells were irradiated (0, 5, 10 or 15 min) with red filter 
allowing the passage of wavelengths superior to 640 nm and with an irradiance of 23.70 
mW/cm2. The assays were performed at different times after irradiation. After irradiation, 
the cells were incubated in the dark at the indicated time (0, 3, 6 and 19 or 24 h). The 
treatment with CPT 20 µM was adding it for 24 h. MMS 25 mM was added to the cells 
for 15 min at 37ºC,wash with PBS before addition of fresh media for 18 h. Porphyrins 
were previous synthesized but CPT and MMS were purchased from Sigma-Adrich. Stock 
solutions of CPT dissolved in DMSO were prepared with concentration of 5.0 mM. MMS 
was prepared from a 200 µL of a stock solution in DMSO in order to have 25 mM of final 
concentration.  
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The dark controls correspond to cells incubated with the compounds without 
irradiation. The light controls are irradiated cells without compound. This last control is 
the one used to calculate the survival rates in the survival assays. 
 
 
3.7.5 Light source 
Four fluorescent tubes aquarelle TLD-15W (Philips) with an irradiance of 23.70 
W/m2. Two red filters with a cut off at 640 nm that were used for all the assays. 
 
 
3.7.6 WST-1 assay 
Cells plated in a 96-well plate were exposed to synthetic compound and irradiated 
or not. 24 h post-irradiation or mock treatment, WST-1 (Roche, Switzerland) reactive 
diluted 1/30 was added to cells. After 30-60 min at 37ºC, the absorbance was measured 
at 450 nm and 690 nm as recommended by the manufacture on a Multiskan MS Plate 
Reader (LabSystems). Each experimental point is the mean of three independent 
experiments. The percentage of viable cells treated with the drugs was calculated 
assuming that the control cells had 100% of viability.  
 
 
3.7.7 ATPliteTM kit assay 
The ATPliteTM kit was purchased from PerkinElmer® (Massachusetts, USA). The 
cells were grown in a black bottom 96-well plate and each compound was added in order 
to have a final volume of 100 µL per well. After 3 h of incubation, the cells were irradiated 
for 15 min. After 24 h, 50 µL of mammalian cell lysis buffer were added to each well and 
the plate was shaken for 5 min. Subsequently, 50 µL of substrate solution was added to 
each well and the plate was shaken for 5 min. Then the plate placed in the dark for 10 min 
and the luminescence between 400-650 nm measured. Multiskan MS Plate Reader 
(LabSystems) was used to shake the plates with the “fast” velocity selected. The 
luminescence was measured in the EnSpire® 2300 multilabel reader (PerkinElmer, 
Massachusetts, USA). The percentage of viable cells treated with the drugs was calculated 
assuming that the control cells had 100% of viability.  
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3.7.8 Trypan Blue assay 
For the pictures with the trypan blue, the cells were plated in small circular dishes 
and after the photodynamic treatment the media was removed and 400 µL of trypan blue 
0.4% in PBS (AMRESCO®) plus 400 µL of PBS were added. Finally, the pictures were 
taken directly from the plate with a camera Leica DFC 420C. 
 
 
3.7.9 Cellular uptake 
MCF-7 cells were incubated for 3 h with each porphyrin at 10 µM in a 96 well-
black plate with clear bottom (Greiner). Then the wells were washed with PBS for 1 min 
and DMSO 99% (Sigma-Aldrich) was added. The plates were shacked for 10 min and the 
fluorescence measured at the appropriate wavelength (Table 9). The fluorescence 
measurements were done by using EnSpire® Alpha Plate Reader (PerkinElmer, 
Massachusetts, USA).  
Table 9. Excitation wavelengths (nm) and the spectrum window (nm) for each PS. 
Porphyrin λexc (nm) Spectrum window (nm) 
5 425 600-850 
6 425 600-800 
TMPyP 425 600-800 
 
Several washing conditions (Table 10) were tried but it did not influence the 
results.  
Table 10. Washing conditions used in the cellular uptake. 
Assay No. 1 2 3 4 5 6 
Volume of PBS (µL) 150 200 250 300 300 300 
No. of washings 3 3 3 3 4 5 
 
 
3.7.10 Subcellular localization 
MCF-7 cells were seeded on coverslips placed into 24-well plates and allowed to 
grow for 24 h. After that the cells were incubated for 3 h with each PS at defined 
concentrations. The cells were fixed for 20 min with 4% p-formaldehyde-PBS, washed 
  Chapter 3 
University of Aveiro  91 
with PBS 3 times for 5 min and then incubated with Hoechst 33342 (Fisher) for 10 min. 
After 3 additional PBS washes the coverslips were mounted on glass slides with Mowiol 
(Sigma-Aldrich). The pictures of subcellular localization were taken with a Leica TCS 
SP5 confocal microscope using a 63×/1.30 GLYC objective. Hoechst was excited at 405 
nm and the fluorescence detected from 417 nm to 446 nm. Porphyrins were excited at 
488 nm with a detection reading from 608 to 699 nm. The photographs were processed 
using Adobe Photoshop CS software (Adobe systems, San Jose, USA). 
 
 
3.7.11 The Western Blot Technique 
Western blot, also called immunoblotting is a technique used very often to detect 
specific proteins in a sample extract. First it is necessary to extract all proteins from the 
cell cytosol and to do a protein dosage in order to load the same amount of protein in each 
well of the electrophoresis gel. The proteins are denatured before loading in a Tris 
buffered solution containing SDS (an anionic detergent) that covers and unfold the 
protein, Beta mercaptoethanol that reduces disulfide bounds, glycerol (to sink easily into 
the wells) and bromophenol dye (to check how the proteins concentrate in the 
concentrating gel due to different pH in both gels.). The sample is heated in order to 
denature the proteins structure. This denaturation process allows the protein to acquire 
negative charge allowing the proteins to have the same charge and move in an electrical 
field. The proteins are then separated according to size by gel electrophoresis.126,127 
There are two types of gels (stacking and separating gel). The first one 
concentrates the proteins due to its pH and low acrylamide concentration which leads to 
a porous gel. The separating gel has higher pH and concentration in polyacrylamide 
which makes the pores narrower and the proteins are separated by their size. The smaller 
proteins will travel faster.127,128 (Figure 50) 
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Figure 50. a- Samples running through the stacking gel (lower voltage) and b- samples running through the 
separation gel (higher voltage). 127 
 
After separation of the proteins, they are transferred to a membrane.129,130 The 
transfer is done by using an electric field oriented perpendicular to the surface of the gel 
leading to the movement of the proteins to the membrane. This type of transfer is called 
electrophoretic transfer. The membranes can be nitrocellulose or polyvinylidene fluoride 
(PVDF). The last is used more often because it allows to reprobing and storage, unlike 
the first one.127,128 (Figure 51 and Figure 52) 
 
Figure 51. The constitution of the sandwich in the western blot. 127 
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Figure 52. PVDF membrane after transfer. 127 
 
Before incubation with the antibody, it is necessary to wash the membrane and 
block the non-specifically bound between the antibodies and the membrane.128 Usually, 
this blockage is done with 5% skimmed milk or BSA diluted in TBST. Skimmed milk is 
preferred over BSA due to its cheaper price and readily availability.127 
The membranes are first incubated with primary antibodies and then with a 
horseradish peroxidase coupled secondary antibody. The concentration of the antibody 
depends on the manufacturer instructions. After incubation with the primary and 
secondary antibody, the membrane should be washed with TBST. The membrane are 
revealed by chemiluminescence with a luminol-based substrate (ECL detection from 
Amersham). This signal is captured with a camera.127,130 
Usually, the uniformity of the loading  is verified by checking the level of a 
reference protein which is not affected by the study (like HSP60, α-tubulin) in each 
sample.131 
 
 
3.7.12 Protein extraction 
3.7.11.1 Harvest 
MCF-7 cells were plated in individual dishes of 20 cm2. After the photodynamic 
treatment, the cells were washed in cold PBS and collected with a scraper. Following 
harvesting, they were suspended in PBS, washed and centrifuged at 1000 rpm at 4ºC for 
30 s.  
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3.7.11.2 Total Protein extraction 
The pellets were suspended in lysis buffer. After an incubation period of 15 min 
on ice, the extracts were centrifuged at 1000 rpm at 4ºC. Then, the supernatants containing 
the total protein extracts were stored at -80ºC. 
 
 
3.7.11.3 Protein Dosage 
The concentration in protein of each cellular extracts was determined by the  Bio-
Rad Protein Assay  based on the method ofBradford. It is a colorimetric assay relying on 
a dye which changes of absorbance in presence of proteins. The readings are effectuated 
at 595 nm in a multiskan MS plate reader. The calibration curved is obtained with BSA 
(bovine serum albumin) standard.  
 
 
3.7.11.4 SDS-Page and Immuno-detection (Western Blotting)  
The appropriate volume of loading buffer (TR4x) was added to each extracts and 
boiled at 100ºC for 3 min.  Then, 5-30 µgr of denatured proteins were loaded onto the 
gel. The same protein amount was added in each well to allow comparison. 4 µL of a 
prestained protein ladder (New England Biolabs® inc., France) was loaded. 
Proteins were separated by SDS-PAGE and the percentage of 
polyacrylamide/bisacrylamide used for each protein is given in Table 11. The 
electrophoresis was run at 90 V until each sample enters the gel and then for 120 V with 
migration buffer 1x until the tracking dye reaches the bottom. After the separation, the 
proteins were electrotransfered on a PVDF membrane (GEHealth Care, Belgium) 
overnight at 45 V in transfer buffer. 
 
Table 11. Percentage in polyacrylamide/bisacrylamide used in this study.  
Protein analysed  Gel Percentage (%) 
PARP 8% 
LC3 15% 
Cyclophilin  15% 
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In order to block the non-specific interacting sites, the membranes were incubated 
with TBST-milk 5% for 1 h at room temperature. Then the membranes were incubated 
with the respective primary antibody for 2 h which detects the desired specific proteins 
(the concentration was optimized for each antibody) (Table 12). 
 
Table 12. List of antibodies and its properties used. 
Antibody Company Reference Dilution Solvent Source 
PARP-1 Cell 
signalling, 
Netherlands  
9542 1/1000 Milk-TBST 
5% 
Rabbit 
LC3-I and II Axxor 
(enzolife 
sciences), 
USA 
0231-
100/LC3-
5f10 
1/500 Immunoboost  Mouse 
Cyclophilin  Cell 
signalling, 
Netherlands  
2175s 1/1000 Milk-TBST 
5% 
Rabbit 
HSP60 Enzo life 
sciences, 
USA 
SPA-806 1/1000 Milk-TBST 
5% 
Mouse 
 
After washing the membranes with TBST, they were incubated with the secondary 
antibody-HRP (House radish peroxidase) (1/1000 dilution) (Dako Cytomation, Denmark 
or cell signalling). After washing, ECL (enhanced chemiluminescence) western blotting 
substrate was added. The membranes were revealed using a LAS4000 Biomolecular 
Imager system (GE Healthcare Life Sciences)  . The molecular weight of the fragments 
was estimated by comparison with PageRulerTM Prestained Protein Ladder. The loading 
control of each membrane (except for Cyclophilin) was anti-HSP60 
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3.7.13 Total RNA extraction 
Cells were plated in a 6-well plate and the photodynamic treatment was applied. 
The total RNA extraction was done with the “high Pure RNA isolation kit” (Roche, 
Switzerland). The cells were washed with PBS and 600 µL of Lysis buffer solution (Lysis 
buffer+ water 2:1) was added to each well. Then the cells were scrapped and placed on 
top of the filter tube and centrifuged for 30 s at 12.000 rpm at 20ºC. After discarding the 
content of the collection tube, each sample was incubated with 100 µL of DNase I 
incubation buffer + DNase I (9:1) for 15 min at room temperature. Then three washes 
followed by 30 s centrifugation at 12.000 rpm at room temperature with 500 µL of Wash 
Buffer 1, 500 µL and 200 µL of Wash Buffer 2 were performed. At the end, the purified 
RNA was eluted by adding   100 µL of elution buffer atop the filter tube and centrifugating  
1 min at 12.000 rpm at room temperature. The eluates were stored at -80ºC 
 
 
3.7.14 RNA dosage 
The extracted RNA was quantified on a spectrometer ND-1000 Nanodrop 
(Thermo Fisher Scientific, Massachusetts, USA) by measuring the absorbance at 260 nm. 
Stock solutions were prepared in order to have a concentration of 4 ng/µL. 
 
 
3.7.15 Generation of cDNAs by reverse transcriptase and 
amplification by PCR 
10 ng/µL of total RNAs was used as a template for cDNA synthesis. RT was 
performed using thermostable rTth reverse transcriptase (from Thermus Thermophilus 
H-8) (RNA PCR kit) (Roche, Switzerland) by incubating it with the RNA samples at 
70ºC. RT was carried out by preparing the reverse transcription reaction mixes with 
transcript-specific-reverse primer (Table 13). Primers were obtained from Eurogentec 
(Liège, Belgium). The cDNAs fragments obtained were later amplified by PCR in the 
amplification buffer with both reverse and forward primers and the same polymerase.
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 Table 13. Sequences of the primers used for RT-PCR analysis.  
 
Target 
mRNA 
Target exon/ 
intron 
Primers Length (bp) 
COASY E4-5 Fwd: 5’ TTC-CGC-CAG-CGA-ATG-TTG-GG 3’ FL: 355 bp/ ΔE-4 150 bp /  
ΔE4-5:100 bp Rev: 5’ CTC-GGG-CCA-GCT-TTG-CGA-TA 3’ 
AMZ2 E3 Fwd: 5’ GCC-AGT-GAT-CTC-TTT-GGA-CCC-ATT 3’ FL:452bp/ ΔE3:278 bp 
Rev: 5’ GTC-AAA-GAG-GCC-TGT-CCA-AAG-ACA 3’ 
P53 E2-3 Fwd: 5’ CCT-ATG-GAA-ACT-ACT-TCC-TG 3’ 333 bp  
Rev: 5’ AGG-GGA-CTA-CGT-GCA-AGT 3’ 
P53 E2 Fwd: 5’ CGA-AAC-ATT-TTC-AGA-CCT-ATG-G 3’ 365 bp 
Rev: 5’ AGG-GGA-CTA-CGT-GCA-AGT 3’ 
P53  I2 Fwd: 5’ ATG-GGA-CTG-ACT-TTC-TGC-TCT 3’ 343 bp 
Rev: 5’ AGG-GGA-CTA-CGT-GCA-AGT 3’ 
P53 E2 (bis) Fwd: 5’ CCC-TCT-GAG-TCA-GGA-AAC 3’ 455 bp 
Rev: 5’ AGG-GGA-CTA-CGT-GCA-AGT 3’ 
ATF3  Fwd: 5’ ATG-ATG-CTT-CAA-CAC-CCA-GGC 3’ FL: 546 bp / ATF3ΔZip2a: 858 bp / 
ATF3ΔZip2b: 767 bp Rev: 5’ TTA-GCT-CTG-CCA-TGT-TCC-TTC 3’ 
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PCR program was carried out for 35 cycles. The temperature of annealing and 
length of the elongation steps depended in which mRNA we were targeting. (Table 14) 
Table 14. Conditions for each phase of a PCR cycle 
Gene Phase Temperature (ºC) Time 
COASY 
AMZ2 
Initial denaturation  94 5 min 
Melting 94 15 s 
Annealing 66 20 s 
Extension  72 30 s 
Final polymerization  72 5 min 
P53 I2 Initial denaturation  94 5 min 
Melting 94 30 s 
Annealing 54 30 s 
Extension  72 75 s 
Final polymerization  72 5 min 
P53 E2 (bis) 
P53 E2/3 
 
 
Initial denaturation  94 5 min 
Melting 94 30 s 
Annealing 58 30 s 
Extension  72 75 s 
Final polymerization  72 5 min 
ATF3 
P53 E2 
Initial denaturation  94 5 min 
Melting 94 30 s 
Annealing 50 30 s 
Extension  72 75 s 
Final polymerization  72 5 min 
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3.7.16 Analysis on polyacrylamide gel 10% 
10 µL of each PCR product was separated by electrophoresis on a 10% 
acrylamide/bisacrylamide gel in TBE 1x buffer and 10 µL of DNA ladder sample was 
added to estimate the bp of each PCR product. The gel ran for 180 V for 1 h. Then the 
PCR products were revealed by staining of each gel with 13 mL TBE 1x + 1.3 µL of 
gelstarTM (Invitrogen, California, USA) for 20 min. The fluorescence was monitored by 
the LAS4000 Biomolecular Imager and the bands quantified by the Image Quant Las 
4000 software (GE Healthcare Life Sciences) 
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4. Conclusion and future outcomes. 
In this work were synthesized and characterized the N-confused and the regular 
porphyrins 1 and 5 (Figure 53), that were used as templates to obtain the correspondent 
cationic derivatives 2 and 6 (Figure 53). The synthesis of the neutral porphyrins occurred 
with a yield of 9% and 23% for porphyrin 2 and 5. The access to the neutral derivatives 
required the previous preparation of 4-bromomethylbenzaldehyde that was obtained in 
19% yield by oxidation of 1,4-bis(bromomethyl)benzene with MnO2. The protocol 
selected to prepare the neutral macrocycles was based on the condensation of that 
benzaldehyde with pyrrole in the presence of MSA, under Lindsey conditions. This 
strategy allowed to obtain both neutral derivatives in the same reaction, porphyrin 1 in 
9% yield and porphyrin 5 in 23%. The lower yield of the N-confused porphyrin is 
probably associated with some self-autopolymerisation involving the nitrogen of the 
inverted pyrrole and the bromomethyl substituent in the aryl groups during the work-up. 
The cationization of the neutral templates with pyridine allowed to obtain compounds 2 
(82%) and 6 (90%) in excellent yields. So, considering the protocol selected it will be 
important to improve the experimental conditions in order to obtain in better yields the 
aldehyde and the neutral porphyrin derivatives. 
 
Figure 53. All synthesized porphyrin derivatives used in this work. 
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The photophysical characterization of the synthesized derivatives showed that 
only the regular porphyrin 5 and 6 are fluorescent. When the capacity of the different 
derivatives in generating 1O2 was evaluated, it was verified that the best PSs were the 
regular porphyrin 5 (even better than TPP), followed by 6; this cationic derivative, under 
the conditions used, showed a much higher efficiency to generate known 1O2 than the 
conventional TMPyP. The presence of an inverted pyrrole ring in the N-confused 
porphyrins seems to reduce their ability to generate 1O2, being the worse performance 
observed for derivative 1 (similar to TMPyP) followed by 2. Although it is described in 
literature that some N-confused porphyrins with different substituents in meso positions 
can generate high amounts of singlet oxygen,100 our results suggest that this efficiency 
must be strongly related with those meso-substituents. So, it would be interesting in future 
work to try the cationization of 1 and even 5 with different groups in order to verify if the 
performance of these cationic N- confused derivatives to generate singlet oxygen can be 
improved; probably even more efficient 1O2 generator than the cationic regular porphyrin 
6 would be obtained.  
In the second part of this work, where it was evaluated photodynamic action of 
the synthesized derivatives to kill breast cancer MCF-7 and HeLa cells, the PDT results 
were compared with the ones obtained with TMPyP, one of the most studied PS in this 
field.  
In the preliminary assays, the results obtained showed that the cationic regular 
porphyrin 6 was the one that has the highest photo-killing action, even higher than the 
positive control TMPyP. The high photo-killing effect also observed with TMPyP 
confirms the results reported in literature.69 It is important to highlight that these first PDT 
studies involving porphyrin 6 seem very promising and merits to be developed.  
The studies concerning the cellular uptake and subcellular localization studies 
were only performed with the fluorescent derivatives 5, 6 and TMPyP and it was verified 
that their uptake by the MCF-7 cells was efficient; however, only TMPyP accumulates 
in the nucleus. Although porphyrin 5 is the best 1O2 generator and is able to enter in the 
cells, probably the subcellular localization is not ideal to promote photokilling. A 
different situation was observed with porphyrin 6 which showed the highest photokilling 
effect; future studies are required in order to clarify its localization in the cell. Since only 
this cationic porphyrin and TMPyP showed relevant cell mortality (more or less 50%), 
they were selected to clarify the type of cell death involved after PDT and the studies of 
alternative splicing.  
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The cell death studies, both cationic PSs 6 and TMPyP seem to induce an 
autophagic flux and the disappearance of full length PARP without the appearance of the 
known apoptosis related cleaved forms. Moreover, there is an accumulation of 
cyclophilin for both porphyrins which suggest that beyond autophagy the cells undergo 
necrosis as well.  
It is also necessary to repeat the alternative splicing assays with ATF3 and p53 
genes, adjusting the PCR conditions such as temperature and/or time or in case of p53 
gene, trying to design more primers since there are several isoforms of this gene. 
PDT can cause oxidative stress and by inducing alternative splicing, new protein 
isoforms can be formed. Cancer cells are characterized by having several protein isoforms 
which avoid cell death but the canonical form promotes it. So, if PDT seems to induce 
AS, maybe the isoforms formed can induce the cell death shown earlier in this chapter. 
However further tests should be done in order to identify which isoform of a promoting 
cell death protein is present in MCF-7 after PDT. 
There are several studies about new alternative spliced isoforms caused by 
genotoxic agents.67,91–93 However, it is important to highlight that regarding the effect of 
photodynamic therapy on alternative splicing, there is not any study exploring this theme. 
So, this work becomes relevant for its novelty and its continuation can be important to 
find new chemotherapeutic approaches. 
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